-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, RLp3SLsLjxuXoMAIoktcEuySYkHpO44qdCs2lZai4ieWPhdagBqHdKluZlb3ovTK s6NRgVcz3DK/2k8rQv+vvQ== 0001145549-08-000800.txt : 20080506 0001145549-08-000800.hdr.sgml : 20080506 20080506064518 ACCESSION NUMBER: 0001145549-08-000800 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20080330 FILED AS OF DATE: 20080506 DATE AS OF CHANGE: 20080506 FILER: COMPANY DATA: COMPANY CONFORMED NAME: STATS CHIPPAC LTD. CENTRAL INDEX KEY: 0001101873 STANDARD INDUSTRIAL CLASSIFICATION: SEMICONDUCTORS & RELATED DEVICES [3674] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-29103 FILM NUMBER: 08804523 BUSINESS ADDRESS: STREET 1: 10 ANG MO KIO STREET 65 STREET 2: TECHPOINT #05-17/20 CITY: SINGAPORE STATE: U0 ZIP: 569059 BUSINESS PHONE: 6568247777 MAIL ADDRESS: STREET 1: 10 ANG MO KIO STREET 65 STREET 2: TECHPOINT #05-17/20 CITY: SINGAPORE STATE: U0 ZIP: 569059 FORMER COMPANY: FORMER CONFORMED NAME: ST ASSEMBLY TEST SERVICES LTD DATE OF NAME CHANGE: 19991227 6-K 1 u93258e6vk.htm STATS CHIPPAC LTD. STATS CHIPPAC LTD.
Table of Contents

 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the quarter ended March 30, 2008
Commission File Number: 000-29103
STATS CHIPPAC LTD.
 
(Translation of registrant’s name into English)
10 Ang Mo Kio Street 65
#05-17/20 TechPoint
Singapore 569059
(65) 6824-7777
 
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F: þ Form 20-F     o Form 40-F
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): o
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934: o Yes     þ No
If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): Not applicable.
 
 


TABLE OF CONTENTS

SIGNATURES
EX-1 REPORT FOR THE THREE MONTHS ENDED MARCH 30, 2008


Table of Contents

     This report on Form 6-K shall be deemed to be incorporated by reference in the Registration Statements on Form S-8 (file numbers 333-136588, 333-118555, 333-75080 and 333-114232) of STATS ChipPAC Ltd. and to be a part thereof from the date on which this report is furnished, to the extent not superseded by documents or reports subsequently filed or furnished.

 


Table of Contents

SIGNATURES
     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Date: May 6, 2008
         
  STATS ChipPAC Ltd.
 
 
  By:   /s/ Tan Lay Koon    
  Name:   Tan Lay Koon    
  Title:   President & Chief Executive Officer   
 
     
  By:   /s/ John Lau    
  Name:   John Lau    
  Title:   Chief Financial Officer   
 

 


Table of Contents

EXHIBIT INDEX
     
Exhibit   Description of Exhibit
1.
  Report for the Three Months Ended March 30, 2008

EX-1 2 u93258exv1.htm EX-1 REPORT FOR THE THREE MONTHS ENDED MARCH 30, 2008 EX-1 REPORT FOR THE THREE MONTHS ENDED
 

Exhibit 1
     In this quarterly report on Form 6-K, unless otherwise specified or the context requires, the terms “STATS ChipPAC,” “Company,” “we,” “our,” and “us” refer to STATS ChipPAC Ltd. and its consolidated subsidiaries. This quarterly report on Form 6-K contains forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “expect,” “plan,” “intend,” “target,” “anticipate,” “believe,” “estimate,” “predict,” “project,” “potential,” “continue” or the negative of these terms or other comparable terminology. These statements are only predictions and speak only as of the date of this report. These forward-looking statements are based on our current views and assumptions and involve a number of risks and uncertainties that could cause actual events or results to differ materially from those described in the report. Factors that could cause actual results to differ include, but are not limited to, general business and economic conditions and the state of the semiconductor industry; level of competition; demand for end-use applications products such as communications equipment and personal computers; decisions by customers to discontinue outsourcing of test and packaging services; our reliance on a small group of principal customers; our continued success in technological innovations; pricing pressures, including declines in average selling prices; availability of financing; prevailing market conditions; our ability to meet the applicable requirements for the termination of registration under the U.S. Securities Exchange Act of 1934, as amended; our ability to meet specific conditions imposed for the continued listing or delisting of our ordinary shares on the Singapore Exchange Securities Trading Limited (the “SGX-ST”); our substantial level of indebtedness; potential impairment charges; delays in acquiring or installing new equipment; adverse tax and other financial consequences if the South Korean taxing authorities do not agree with our interpretation of the applicable tax laws; our ability to develop and protect our intellectual property; rescheduling or canceling of customer orders; changes in our product mix; intellectual property rights disputes and litigation; our capacity utilization; limitations imposed by our financing arrangements which may limit our ability to maintain and grow our business; changes in customer order patterns; shortages in supply of key components; disruption of our operations; loss of key management or other personnel; defects or malfunctions in our testing equipment or packages; changes in environmental laws and regulations; exchange rate fluctuations; regulatory approvals for further investments in our subsidiaries; majority ownership by Temasek Holdings (Private) Limited (“Temasek”) that may result in conflicting interests with Temasek and our affiliates; unsuccessful acquisitions and investments in other companies and businesses; labor union problems in South Korea; uncertainties of conducting business in China and other countries in Asia; natural calamities and disasters, including outbreaks of epidemics and communicable diseases; and other risks described from time to time in the Company’s filings with the U.S. Securities and Exchange Commission (the “SEC”), including its annual report on Form 20-F dated March 7, 2008. We do not intend, and do not assume any obligation, to update any forward-looking statements to reflect subsequent events or circumstances.
     Since the beginning of fiscal 2005, we have employed quarterly and fiscal year reporting periods. Our 52-53 week fiscal year ends on the Sunday nearest and prior to December 31. Our fiscal quarters end on a Sunday and are generally thirteen weeks in length. Our first quarter of 2008 ended on March 30, 2008, while our first quarter of 2007 and fiscal year 2007 ended on April 1, 2007 and December 30, 2007, respectively. References to “$” are to the lawful currency of the United States of America.

 


 

STATS CHIPPAC LTD. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
In thousands of U.S. Dollars (except per share data)
                 
    December 30,     March 30,  
    2007     2008  
            (Unaudited)  
ASSETS
               
Current assets:
               
Cash and cash equivalents
  $ 213,461     $ 209,750  
Short-term marketable securities
    29,230       53,134  
Accounts receivable, net
    271,360       264,347  
Short-term amounts due from affiliates
    9,292       8,758  
Other receivables
    6,877       13,703  
Inventories
    83,312       83,505  
Prepaid expenses and other current assets
    22,320       20,990  
 
           
Total current assets
    635,852       654,187  
Long-term marketable securities
    15,296       15,809  
Long-term amounts due from affiliates
    6,852       9,635  
Property, plant and equipment, net
    1,276,490       1,271,178  
Investment in equity investee
    10,350       10,257  
Intangible assets
    40,754       41,246  
Goodwill
    547,958       545,340  
Long-term restricted cash
    1,612       1,695  
Prepaid expenses and other non-current assets
    61,790       54,749  
 
           
Total assets
  $ 2,596,954     $ 2,604,096  
 
           
 
               
LIABILITIES AND SHAREHOLDERS’ EQUITY
               
Current liabilities:
               
Accounts and other payables
  $ 164,300     $ 172,109  
Payables related to property, plant and equipment purchases
    70,744       54,733  
Accrued operating expenses
    109,516       116,442  
Income taxes payable
    17,250       12,425  
Short-term borrowings
    50,300       50,300  
Amounts due to affiliates
    1,651       1,510  
Current installments of long-term debts
    190,481       176,048  
 
           
Total current liabilities
    604,242       583,567  
Long-term debts, excluding current installments
    423,853       421,616  
Other non-current liabilities
    125,093       116,635  
 
           
Total liabilities
    1,153,188       1,121,818  
Minority interest
    59,797       66,194  
Share capital:
               
Ordinary shares —
Unlimited ordinary shares with no par value;
Issued ordinary shares — 2,047,333,663 in 2007 and 2,056,983,106 in 2008
    1,891,546       1,899,001  
Accumulated other comprehensive loss
    (7,605 )     (798 )
Accumulated deficit
    (499,972 )     (482,119 )
 
           
Total shareholders’ equity
    1,383,969       1,416,084  
 
           
Total liabilities and shareholders’ equity
  $ 2,596,954     $ 2,604,096  
 
           

 


 

STATS CHIPPAC LTD. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
In thousands of U.S. Dollars (except per share data)
(Unaudited)
                 
    Three Months Ended  
    April 1,     March 30,  
    2007     2008  
 
               
Net revenues
  $ 390,470     $ 427,242  
Cost of revenues
    (312,911 )     (352,704 )
 
           
Gross profit
    77,559       74,538  
 
           
Operating expenses:
               
Selling, general and administrative
    27,999       31,466  
Research and development
    8,185       10,005  
Restructuring expenses
          900  
Tender offer expenses
    6,808        
 
           
Total operating expenses
    42,992       42,371  
 
           
Operating income
    34,567       32,167  
 
           
Other income (expense), net:
               
Interest income
    1,837       1,435  
Interest expense
    (10,464 )     (10,542 )
Foreign currency exchange gain
    120       3,208  
Equity loss from investment in equity investee
    (253 )     (136 )
Other non-operating income, net
    41       728  
 
           
Total other expense, net
    (8,719 )     (5,307 )
 
           
Income before income taxes
    25,848       26,860  
Income tax expense
    (7,651 )     (7,620 )
 
           
Income before minority interest
    18,197       19,240  
Minority interest
    (1,150 )     (1,387 )
 
           
Net income
  $ 17,047     $ 17,853  
 
           
 
               
Net income per ordinary share:
               
— basic
  $ 0.01     $ 0.01  
— diluted
  $ 0.01     $ 0.01  
 
               
Net income per ADS:
               
— basic
  $ 0.08     $ 0.09  
— diluted
  $ 0.08     $ 0.08  
 
               
Ordinary shares (in thousands) used in per ordinary share calculation:
               
— basic
    2,009,832       2,052,159  
— diluted
    2,191,760       2,202,146  
ADS (in thousands) used in per ADS calculation:
               
— basic
    200,983       205,216  
— diluted
    219,176       220,215  


 

STATS CHIPPAC LTD. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
In thousands of U.S. Dollars
(Unaudited)
                 
    Three Months Ended  
    April 1,     March 30,  
    2007     2008  
Cash Flows From Operating Activities
               
Net income
  $ 17,047     $ 17,853  
Adjustments to reconcile net income to net cash provided by operating activities:
               
Depreciation and amortization
    60,779       70,784  
Amortization of leasing prepayments
    11        
Debt issuance cost amortization
    618       1,479  
Loss (gain) on sale of property, plant and equipment
    725       (264 )
Accretion of discount on convertible notes
    1,386       31  
Foreign currency exchange (gain) loss
    (372 )     1,514  
Share-based compensation expense
    2,882       1,240  
Deferred income taxes
    5,822       1,972  
Minority interest in income of subsidiary
    1,150       1,387  
Equity loss from investment in equity investee
    253       136  
Gain on sale of marketable securities
    (72 )     (8 )
Others
    52       69  
Changes in operating working capital:
               
Accounts receivable
    1,014       7,013  
Amounts due from affiliates
    10       (2,249 )
Inventories
    14,506       (193 )
Other receivables, prepaid expenses and other assets
    4,149       (8,431 )
Accounts payable, accrued operating expenses and other payables
    (34,113 )     4,744  
Amounts due to affiliates
    (28 )     (141 )
 
           
Net cash provided by operating activities
    75,819       96,936  
 
           
Cash Flows From Investing Activities
               
Proceeds from sales of marketable securities
  $ 10,327     $ 7,473  
Proceeds from maturity of marketable securities
    2,946       4,589  
Purchases of marketable securities
          (32,908 )
Acquisition of intangible assets
    (614 )     (2,345 )
Purchases of property, plant and equipment
    (55,790 )     (71,227 )
Proceed on sale of assets held for sale
          6,761  
Others, net
    3,203       399  
 
           
Net cash used in investing activities
    (39,928 )     (87,258 )
 
           
Cash Flows From Financing Activities
               
Repayment of short-term debts
  $ (544 )   $  
Repayment of long-term debts
    (38,726 )     (1,884 )
Proceeds from issuance of shares
    11,069       6,150  
Repurchase and redemption of convertible notes
    (36,800 )     (17,571 )
Proceeds from bank borrowings
    15,548        
Decrease (increase) in restricted cash
    4       (81 )
Capital lease payments
    (1,823 )      
 
           
Net cash used in financing activities
    (51,272 )     (13,386 )
 
           
Net decrease in cash and cash equivalents
    (15,381 )     (3,708 )
Effect of exchange rate changes on cash and cash equivalents
    102       (3 )
Cash and cash equivalents at beginning of the period
    171,457       213,461  
 
           
Cash and cash equivalents at end of the period
  $ 156,178     $ 209,750  
 
           


 

STATS CHIPPAC LTD. AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
For the Three Months Ended March 30, 2008
(Unaudited)
Note 1: Interim Statements
     The consolidated balance sheet of STATS ChipPAC Ltd. (“STATS ChipPAC” or the “Company”) as of December 30, 2007, which has been derived from audited consolidated financial statements, and the unaudited condensed consolidated financial statements have been prepared in accordance with the accounting principles generally accepted in the United States of America, but condense or omit certain information and note disclosures normally included in annual financial statements. In the opinion of management of STATS ChipPAC, the accompanying unaudited condensed consolidated financial statements contain all adjustments (consisting solely of normal recurring adjustments) necessary to present fairly the financial information included therein. These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes thereto for the year ended December 30, 2007 included in STATS ChipPAC’s 2007 Annual Report on Form 20-F. The accompanying condensed consolidated financial statements include the accounts of STATS ChipPAC and its subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.
     The Company predominantly utilizes the U.S. Dollar as its functional currency. The Company’s Taiwan subsidiary, STATS ChipPAC Taiwan Semiconductor Corporation, designates the New Taiwan Dollar as its functional currency. Where the functional currency is other than the Company’s U.S. Dollar reporting currency, it is translated into U.S. Dollars using exchange rates prevailing at the balance sheet date for assets and liabilities and average exchange rates for the reporting period for the results of operations. Adjustments resulting from translation of such foreign subsidiary financial statements are reported within accumulated other comprehensive income, which is reflected as a separate component of shareholders’ equity.
     The Company owned approximately 52% of STATS ChipPAC Taiwan Semiconductor Corporation as of March 30, 2008. The shares of STATS ChipPAC Taiwan Semiconductor Corporation are listed on the Taiwan over-the-counter securities market.
     The results of operations for interim periods are not necessarily indicative of the results of operations that may be expected for any other period. Our 52-53 week fiscal year ends on the Sunday nearest and prior to December 31. Our fiscal quarters end on a Sunday and are generally thirteen weeks in length. The first quarter of 2008 ended on March 30, 2008, while the first quarter of 2007 and fiscal year 2007 ended on April 1, 2007 and December 30, 2007, respectively.
Proposed Capital Reduction Exercise
     In January 2008, the Company announced its intention to effect a proposed capital reduction to return surplus share capital in an amount of up to $813.0 million to its shareholders. At an extraordinary general meeting held on March 17, 2008, the shareholders approved the proposed capital reduction. The proposed capital reduction is subject to and conditional upon the Company being able to obtain adequate debt financing to fund the cash distribution and the repayment of certain of its outstanding debt (including the redemption or repurchase of the Company’s 7.5% senior notes due 2010 and 6.75% senior notes due 2011 (“the senior notes”) that would otherwise restrict its ability to make the cash distribution and to finance the cash distribution) on terms and conditions acceptable to the Company. The amount of the cash distribution would accordingly be determined based on the proceeds of such debt financing made available to the Company. The proposed capital reduction is also subject to (1) approval by the Singapore High Court and other applicable regulatory authorities and (2) the board of directors determining, following the satisfaction of the preceding conditions, that it is in the best interest of the Company, to effect the proposed cash distribution.
Temasek’s Subsidiary, Singapore Technologies Semiconductors Pte Ltd’s, Tender Offer
     In March 2007, Singapore Technologies Semiconductors Pte Ltd (“STSPL”), a wholly-owned subsidiary of Temasek Holdings (Private) Limited (“Temasek”), launched a voluntary conditional cash tender offer for the ordinary shares and American Depositary Shares (“ADSs”) of the Company that STSPL did not already own. The tender offer also included an offer by STSPL for the Company’s then outstanding $115.0 million aggregate principal amount of zero coupon convertible notes due 2008 and $150.0 million aggregate principal amount of 2.50% convertible subordinated notes due 2008. Concurrently with the tender offer, STSPL made an options proposal to all holders of options granted under STATS ChipPAC’s share option plans.

 


 

     In May, 2007, the tender offer closed with STSPL and its concert parties holding 83.1% of the outstanding ordinary shares (including ordinary shares represented by ADSs, but excluding the ordinary shares issuable upon the potential conversion of the $134.5 million aggregate principal amount of the 2.5% convertible subordinated notes due 2008 acquired by STSPL) and $134.5 million aggregate principal amount of the 2.5% convertible subordinated notes due 2008. The balance $15.5 million outstanding principal amount of the 2.5% convertible subordinated notes due 2008 was converted into ADSs in May 2007.
     As of March 30, 2008, Temasek, through its wholly-owned subsidiary, STSPL, beneficially owned approximately 82.7% of the Company’s outstanding ordinary shares. As of March 30, 2008, STSPL (and through its ownership of STSPL, Temasek) beneficially owned 1,845,715,689 ordinary shares (including ordinary shares represented by ADSs and ordinary shares into which the $134.5 million aggregate principal amount of 2.5% convertible subordinated notes due 2008 beneficially owned by STSPL may be converted), representing 83.8% of the issued ordinary shares (including in the numerator and the denominator the ordinary shares issuable upon conversion of the 2.5% convertible subordinated notes due 2008 beneficially owned by STSPL).
     In the three and twelve months ended April 1, 2007 and December 30, 2007, respectively, the Company recorded tender offer expenses of $6.8 million and $10.9 million, respectively, consisting of investment banking, legal, accounting, insurance, printing and other costs associated with the tender offer. No tender offer expenses were incurred during the three months ended March 30, 2008.
Recent Accounting Pronouncements
     In September 2006, the FASB issued SFAS No. 157, “Fair Value Measurements” (“SFAS 157”), which defines fair value, establishes guidelines for measuring fair value and expands disclosures regarding fair value measurements. SFAS 157 does not require any new fair value measurements but rather eliminates inconsistencies in guidance found in various prior accounting pronouncements. SFAS 157 is effective for fiscal years beginning after November 15, 2007. The Company adopted SFAS 157 for financial assets and financial liabilities at the beginning of the first quarter of 2008 and its adoption did not have a material impact on the Company’s consolidated financial position and results of operations. In February 2008, the FASB issued staff position No. 157-2 (“FSP 157-2”) which delays the effective date of SFAS 157, for nonfinancial assets and nonfinancial liabilities, except for items that are recognized or disclosed at fair value in the financial statements on a recurring basis (annually). FSP 157-2 is effective for fiscal years beginning after November 15, 2008.
     The Company is currently assessing the impact of SFAS 157 for nonfinancial assets and nonfinancial liabilities on its consolidated financial position and results of operations. SFAS 157 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). SFAS 157 establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows: (Level 1) observable inputs such as quoted prices in active markets; (Level 2) inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and (Level 3) unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.
     The Company utilizes the market approach to measure fair value for its financial assets and liabilities. The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities.
     The following table sets forth the Company’s financial assets and liabilities that were accounted for, at fair value on a recurring basis as of March 30, 2008:
                         
    Fair value measurement as of March 30,
    2008
    Level 1   Level 2   Level 3
Assets:
                       
Marketable securities
  $ 68,943     $     $  
Foreign currency forward contracts
          4,552        
     
 
  $ 68,943     $ 4,552     $  
     
 
                       
Liabilities:
                       
Foreign currency forward contracts
  $     $ 3,171     $  
     
 
  $     $ 3,171     $  
     

 


 

     Unrealized gains or losses on marketable securities and foreign currency forward contracts are recorded in accumulated other comprehensive gain (loss) at each measurement date.
     In September 2006, the FASB issued SFAS No. 158, “Employers’ Accounting for Defined Benefit Pension and Other Postretirement Plans an amendment of FASB Statements No. 87, 88, 106, and 132(R)” (“SFAS 158”). This standard requires employers to recognize the underfunded or overfunded status of a defined benefit postretirement plan as an asset or liability in its statement of financial position and to recognize changes in the funded status in the year in which the changes occur through accumulated other comprehensive income, which is a component of stockholders’ equity. The new reporting requirements and related new footnote disclosure rules of SFAS 158 are effective for fiscal years ending after December 15, 2006. The adoption of SFAS 158 does not have a material impact on the Company’s consolidated financial statements. Additionally, SFAS 158 requires employers to measure the funded status of a plan as of the date of its year-end statement of financial position effective for fiscal year ending after December 15, 2008. The Company is currently evaluating the effect of the requirement of SFAS 158 related to measurement of the funded status of deferred benefit plans on its consolidated financial statements.
     In February 2007, the FASB issued SFAS No. 159 “The Fair Value Option for Financial Assets and Financial Liabilities — including an Amendment of SFAS No. 115” (“SFAS 159”), which permits companies to measure certain financial assets and financial liabilities at fair value. SFAS 159 requires that unrealized gains and losses are reported in earnings for items measured using the fair value option. SFAS 159 amends previous guidance to extend the use of the fair value option to available-for-sale and held-to-maturity securities. SFAS 159 is effective as of the beginning of the first fiscal year beginning after November 15, 2007. The adoption of SFAS 159 at the beginning of the first quarter of 2008 did not have a material effect on the Company’s financial statements.
     In December 2007, the FASB issued SFAS No. 141(R), “Business Combinations” (“SFAS 141(R)”), which replaces SFAS No. 141, “Business Combinations.” SFAS 141(R) retains the underlying concepts of SFAS 141 in that all business combinations are still required to be accounted for at fair value under the acquisition method of accounting but SFAS 141(R) changed the method of applying the acquisition method in a number of significant aspects. Acquisition costs will generally be expensed as incurred; noncontrolling interests will be valued at fair value at the acquisition date; in-process research and development will be recorded at fair value as an indefinite-lived intangible asset at the acquisition date; restructuring costs associated with a business combination will generally be expensed subsequent to the acquisition date; and changes in deferred tax asset valuation allowances and income tax uncertainties after the acquisition date generally will affect income tax expense. SFAS 141(R) is effective on a prospective basis for all business combinations for which the acquisition date is on or after the beginning of the first annual period subsequent to December 15, 2008, with the exception of the accounting for valuation allowances on deferred taxes and acquired tax contingencies. SFAS 141(R) amends SFAS 109 such that adjustments made to valuation allowances on deferred taxes and acquired tax contingencies associated with acquisitions that closed prior to the effective date of SFAS 141(R) would also apply the provisions of SFAS 141(R). If such liabilities are settled for lesser amounts prior to the adoption of SFAS 141(R), the reversal of any remaining liability will affect goodwill. If such liabilities reverse subsequent to the adoption of SFAS 141(R), such reversals will affect the income tax provision in the period of reversal. Early adoption is not permitted. The Company is currently evaluating the effects, if any, that SFAS 141(R) may have on its financial statements; however, since the Company acquired significant deferred tax assets for which valuation allowances were recorded at the acquisition date, SFAS 141(R) could significantly affect the results of operations if changes in the valuation allowances occur subsequent to adoption. As of March 30, 2008, the Company has established deferred tax valuation allowances of $34.9 million in purchase accounting.
     In December 2007, the FASB issued SFAS No. 160, “Noncontrolling Interests in Consolidated Financial Statements — an amendment of ARB No. 51” (“SFAS 160”). SFAS 160 requires the recognition of a noncontrolling (minority) interest as equity in the consolidated financial statements and separate from the parent’s equity. The amount of net income attributable to the noncontrolling (minority) interest will be included in consolidated net income on the face of the income statement. It also amends certain of ARB No. 51’s consolidation procedures for consistency with the requirements of SFAS 141(R). This statement also includes expanded disclosure requirements regarding the interests of the parent and its noncontrolling interest. SFAS 160 is effective for annual periods beginning after December 15, 2008 and should be applied prospectively. However, the presentation and disclosure requirements of the statement shall be applied retrospectively for all periods presented. The Company is currently evaluating the effect of SFAS 160 on its consolidated financial statements and anticipates that SFAS 160 will not have a significant impact on the reporting of its results of operations.
     In March 2008, the FASB issued SFAS No. 161, “Disclosures about Derivative Instruments and Hedging Activities — an amendment of SFAS No. 133” (“SFAS 161”), which is intended to improve financial reporting about derivative instruments and hedging activities by requiring enhanced disclosures to enable investors to better understand their effects on an entity’s financial position, financial performance and cash

 


 

flows. This Statement is effective for financial statements issued for fiscal years and interim periods beginning after November 15, 2008. The Company is currently evaluating the effect of SFAS 161 on its consolidated financial statements.
Share-Based Compensation
     As of December 30, 2007, the Company had outstanding grants under four share-based plans. The Company adopted the fair value recognition provisions of SFAS 123(R) effective December 26, 2005. For share-based awards, the Company recognizes compensation expense on a graded vesting basis over the requisite service period of the award. The share-based compensation expense under SFAS 123(R) was as follows (in thousands):
                 
    Three Months Ended  
    April 1,     March 30,  
    2007     2008  
Cost of revenues
  $ 1,488     $ 586  
Selling, general and administrative
    1,018       515  
Research and development
    376       139  
 
           
 
  $ 2,882     $ 1,240  
 
           
     In January 2008, the Company decided to terminate the STATS ChipPAC Ltd. Restricted Share Plan (the “RSP”), the STATS ChipPAC Ltd. Performance Share Plan (the “PSP”) and the STATS ChipPAC Ltd. Employee Share Purchase Plan 2004 (the “ESPP”), to be effective in end March 2008. The STATS ChipPAC Share Option Plan, as amended, was phased out as of December 2006 and replaced by the RSP. No Restricted Share Units (“RSUs”), contingent Performance Share Plan awards and share options were granted in the three months ended March 30, 2008.
     The Company estimates the grant-date fair value of share options using the Black-Scholes option-pricing model. The Black-Scholes option-pricing model incorporates various and highly subjective assumptions including expected volatility, expected term and interest rates. The expected volatility is based on the implied volatility and trading history of the Company’s shares over the most recent period that commensurate with the estimated expected term of the Company’s share options. The estimated term of the Company’s share options is derived from historical experience. Estimates of fair value are not intended to predict actual future events or the value ultimately realized by persons who receive equity awards.
     The Company estimates the fair value of RSUs based on the market price of ordinary shares on the date of grant. The fair value of contingent PSP awards is calculated using the market price of ordinary shares on the date of award, adjusted to the market-based performance conditions represented by total shareholders’ return on a certain set of absolute and relative to benchmark company criteria.
     SFAS 123(R) requires the cash flows resulting from the tax benefits for tax deductions in excess of the compensation expense recorded for those options (excess tax benefits) to be classified as financing cash flows. For the three months ended April 1, 2007 and March 30, 2008, the windfall tax benefit realized from exercised employee share options were insignificant.
     Concurrently with the tender offer (refer to “Temasek’s Subsidiary, Singapore Technologies Semiconductors Pte Ltd’s, Tender Offer” in Note 1), STSPL made an options proposal to all holders of options granted under STATS ChipPAC’s share option plans whereby the participating holders would agree not to exercise their options for new shares or to exercise their rights as option holders. During the tender offer period, 85,348,090 options were surrendered pursuant to the options proposal.

 


 

     The following table summarizes share option activity during the three months ended March 30, 2008:
                         
            Weighted    
            Average   Aggregate
    Options   Exercise Price   Intrinsic Value
    (In thousands)           (In thousands)
Options outstanding at December 31, 2007
    15,986     $ 1.70          
Lapsed and forfeited
    (234 )     1.87          
Exercised
    (26 )     0.69          
 
                       
Options outstanding at March 30, 2008
    15,726     $ 1.80     $ 83  
 
                       
 
                       
Exercisable at March 30, 2008
    15,553     $ 1.52     $ 51  
 
                       
     The aggregate intrinsic value in the table above is based on the difference between the market price and the price payable by option holders to exercise their options. During the three months ended April 1, 2007 and March 30, 2008, the total amount of cash received from the exercise of share options was $5.3 million and $0.02 million, respectively.
     The following table summarizes information about share options outstanding at March 30, 2008:
                                                 
    Options Outstanding   Options Exercisable
            Weighted                   Weighted    
            Average   Weighted           Average   Weighted
Range of   Number   Remaining   Average   Number   Remaining   Average
Exercise   Outstanding at   Contractual   Exercise   Exercisable at   Contractual   Exercise
Prices   3/30/2008   Life   Price   3/30/2008   Life   Price
    (In thousands)                   (In thousands)                
$0.14 to $0.15
    21     1.6 years   $ 0.14       21     1.6 years   $ 0.14  
$0.22 to $0.29
    31     4.7 years   $ 0.29       31     4.7 years   $ 0.29  
$0.43 to $0.47
    1     3.0 years   $ 0.46       1     3.0 years   $ 0.46  
$0.55 to $0.87
    569     4.6 years   $ 0.76       396     4.1 years   $ 0.81  
$0.91 to $1.07
    3     3.1 years   $ 1.02       3     3.1 years   $ 1.02  
$1.16 to $1.64
    14,072     4.0 years   $ 1.39       14,072     4.0 years   $ 1.39  
$2.04 to $2.61
    208     1.7 years   $ 2.09       208     1.7 years   $ 2.09  
$3.99
    821     2.1 years   $ 3.99       821     2.1 years   $ 3.99  
 
                                       
 
    15,726     3.9 years             15,553     3.9 years        
 
                                       
     The following table summarizes information on RSUs and contingent PSP awards outstanding as of March 30, 2008:
                                                 
    RSP   Contingent PSP
            Weighted                   Weighted    
            Average                   Average   Aggregate
    Number of   Grant-Date   Aggregate   Number of   Grant-Date   Intrinsic
    shares   Fair Value   Intrinsic Value   shares   Fair Value   Value
    (In thousands)           (In thousands)   (In thousands)           (In
                                            thousands)
Outstanding as at December 31, 2007
    6,302     $ 0.86               2,980     $ 0.85          
Lapsed and forfeited
    (168 )     0.84               (45 )     0.85          
Vested
    (1,997 )     0.84     $ 1,879                      
 
                                               
Outstanding as at March 30, 2008
    4,137     $ 0.86               2,935     $ 0.85     $  
 
                                               
     The aggregate intrinsic value in the table above represents the value of the ordinary shares on the date that the RSUs and contingent PSP awards vest.
     During the three months ended March 30, 2008, 2.0 million ordinary shares were issued pursuant to the RSUs. No issue of contingent PSP awards was made during the three months ended March 30, 2008. The fair value of the contingent PSP awards for the three months ended April 1, 2007 was calculated with the following assumptions:
         
    Three Months Ended
    April 1,
    2007
Expected term
  3 years
Dividend yield
    0.0 %
Risk free interest rate
    3.0 %
Weighted average volatility
    40.0 %

 


 

     For the employee share purchase rights under the terms of the ESPP, the total number of shares to be purchased under the plan and the Company’s matching contribution of up to 20% of the contribution of the ESPP participants, by transferring or issuing shares or providing cash contribution for the purchase of shares, can vary as the purchase price per share is determined based on the fair market value at the end of the purchase period. Therefore the final measure of compensation cost for these rights is determined at the end of the purchase period, on which the number of shares an employee is entitled and the purchase price are determinable. The Company calculates estimated compensation cost as of the balance sheet date prior to the end of the purchase period based on the current estimation of the number of shares to be purchased under the plan and the level of contribution, as determined in accordance with the terms of the ESPP. The ESPP was terminated effective end March 2008.
     As of March 30, 2008, there was $0.01 million of unrecognized share-based compensation expense related to approximately 0.2 million of unvested share option awards net of $0.002 million of estimated share option award forfeitures. This cost is expected to be recognized over a weighted-average period of 1.4 years.
     As of March 30, 2008, there were $1.9 million and $1.6 million of unrecognized share-based compensation expenses related to approximately 4.1 million of unvested RSUs and 2.9 million of unvested contingent PSP awards, respectively, net of $0.1 million of estimated RSU forfeitures. These costs are expected to be recognized over a weighted-average period of 1.5 years and 1.9 years for the RSUs and the contingent PSP awards, respectively.
     During the three months ended March 30, 2008, the total grant-date fair value of share options that vested were $3.1 million. The total intrinsic value of share options exercised during the three months ended March 30, 2008 was insignificant. For the three months ended March 30, 2008, the value of the 7,625,760 shares issued for ESPP purchases were $6.1 million and employees contributed $4.7 million to the ESPP.
Share Repurchase Program
     At the annual general meeting in April 2008, the Company obtained shareholders’ approval for the repurchase of up to approximately 51 million ordinary shares (2.5% of the issued ordinary share capital as of the date of the annual general meeting). The approved amount for share repurchases under this shareholders’ mandate will terminate on the earlier of the date on which the next annual general meeting is held or the date which the approval is revoked or varied. As of March 30, 2008, the Company had not repurchased any shares.
Other Comprehensive Income (Loss)
     The components of accumulated other comprehensive loss on December 30, 2007 and March 30, 2008 comprised the following (in thousands):
                 
    December 30,     March 30,  
    2007     2008  
Currency translation loss
  $ (7,086 )   $ (1,643 )
Unrealized gain on hedging instruments
    378       1,229  
Unrealized loss on available-for-sale marketable securities
    (897 )     (384 )
 
           
 
  $ (7,605 )   $ (798 )
 
           
     Comprehensive income (loss) for the three months ended April 1, 2007 and March 30, 2008 were as follows (in thousands):
                 
    Three Months Ended  
    April 1,     March 30,  
    2007     2008  
Net income
  $ 17,047     $ 17,853  
Other comprehensive income (loss):
               
Unrealized gain on available-for-sale marketable securities
    232       513  
Realized gain on available-for-sales marketable securities included in net income
    (72 )      
Unrealized loss on hedging instruments
    (505 )     (131 )
Realized loss on hedging instruments included in net income
    21       982  
Foreign currency translation adjustment
    (809 )     5,443  
 
           
Comprehensive income
  $ 15,914     $ 24,660  
 
           

 


 

Hedging Instruments
     The Company recognizes all derivatives as either assets or liabilities in the consolidated balance sheets and measures those instruments at fair value. Changes in the fair value of those instruments will be reported in earnings or other comprehensive income depending on the use of the derivative and whether it qualifies for hedge accounting. The accounting for gains and losses associated with changes in the fair value of derivatives and the effect on the consolidated financial statements will depend on the derivatives’ hedge designation and whether the hedge is highly effective in achieving offsetting changes in the fair values of cash flows of the asset or liability hedged.
     The Company operates in various countries, and accordingly, is subject to the inherent risks associated with foreign exchange rate movements. The Company has established risk management policies for committed or forecasted exposures to protect against volatility of future cash flows. These programs reduce, but do not always entirely eliminate, the impact of the currency exchange or commodity price movements. At March 30, 2008, the Company had a series of foreign currency forward contracts with total contract value of approximately $203.1 million. These forward contracts qualify for cash flow hedge accounting as defined by SFAS No. 133, “Accounting for Derivative Instruments and Hedging Activities.The duration of these instruments are generally less than 12 months. During the three months ended March 30, 2008, the Company had realized loss of $1.0 million and unrealized loss of $0.1 million, respectively, on its foreign currency forward contracts qualifying as cash flow hedges. Certain foreign currency forward contracts to economically hedge certain committed exposures are not designated as hedges. Accordingly, the changes in fair value of these foreign currency forward contracts are reported in earnings.
Note 2: Selected Balance Sheet Accounts
     The components of inventories were as follows (in thousands):
                 
    December 30,     March 30,  
    2007     2008  
Raw materials
  $ 65,877     $ 68,013  
Work-in-progress
    14,872       14,523  
Finished goods
    2,563       969  
 
           
 
  $ 83,312     $ 83,505  
 
           
     Prepaid expenses and other current assets consist of the following (in thousands):
                 
    December 30,     March 30,  
    2007     2008  
Other prepayments and assets
  $ 8,241     $ 10,847  
Deferred income tax assets
    1,207       1,213  
Loans to a vendor
    3,529       3,529  
Assets held for sale
    9,343       5,401  
 
           
 
  $ 22,320     $ 20,990  
 
           
     Prepaid expenses and other non-current assets consist of the following (in thousands):
                 
    December 30,     March 30,  
    2007     2008  
Leasing prepayments
  $ 248     $ 413  
Deferred income tax assets
    39,609       37,399  
Other deposits
    303       446  
Loans to a vendor
    882        
Debt issuance cost, net of accumulated amortization of $7,958 and $4,439
    6,949       5,470  
Assets held for sale
    10,544       7,286  
Others
    3,255       3,735  
 
           
 
  $ 61,790     $ 54,749  
 
           
     The Company extended $5.0 million and $15.0 million loans to a vendor in June 2003 and January 2004, respectively, to secure a specified minimum quantity of substrates up to December 2008. The loans are interest-free and are collateralized by equipment purchased by the loan monies, mortgage on the factory of the

 


 

vendor and 2,400 shares of the vendor’s equity. The loans of $5.0 million and $15.0 million are repayable by quarterly installments of $0.4 million and $0.9 million up to June 2007 and December 2008, respectively. During the three months ended March 30, 2008, $0.9 million was repaid.
     In May 2007, the Company entered into an agreement to sell packaging and test equipment related to discrete power packages to Ningbo Mingxin Microelectronics Co. Ltd. (“Mingxin”) for an aggregate consideration of $10.0 million payable over approximately two years. The Company has separately classified the related assets of $10.0 million as assets held for sale, a component of other current assets. During the three months ended March 30, 2008, $3.9 million of the assets have been transferred to Mingxin. These held for sale assets were recorded at the lower of carrying amount or fair value less cost to sell.
     In 2006, the Company entered into an agreement to sell packaging and test equipment related to specific low lead count packages to Wuxi CR Micro-Assembly Technology Ltd. (“ANST”) for $35.0 million payable over 4 years and a performance-based contingent earn-out of $5.0 million. ANST is a wholly owned subsidiary of Micro Assembly Technologies Limited (“MAT”), of which the Company has a 25% equity interest. As a result of the planned transfer of these assets to ANST, the Company has separately classified the related assets of $29.6 million to assets held for sale, a component of other non-current assets. During the three months ended March 30, 2008, $3.3 million of the related assets have been transferred to ANST and $0.06 million of gain were recognized in the three months ended March 30, 2008. In addition to the transfer of assets, the Company entered into an agreement to provide sales and technical support to ANST on a quarterly commission basis from 2007 to 2009, of which $0.2 million was earned in the three months ended March 30, 2008.
     Restricted cash consists of time deposits and government bonds held in connection with foreign regulatory requirements and as collateral for bank loans. At December 30, 2007 and March 30, 2008, $1.6 million and $1.7 million, respectively, were held as long-term restricted cash.
     Property, plant and equipment consist of the following (in thousands):
                 
    December 30,     March 30,  
    2007     2008  
Cost:
               
Freehold land
  $ 11,010     $ 11,295  
Leasehold land and land use rights
    19,864       19,864  
Buildings, mechanical and electrical installation
    262,186       265,504  
Equipment
    2,145,503       2,197,784  
 
           
Total cost
    2,438,563       2,494,447  
Total accumulated depreciation
    (1,162,073 )     (1,223,269 )
 
           
Property, plant and equipment, net
  $ 1,276,490     $ 1,271,178  
 
           
     Intangible assets consist of the following (in thousands):
                                                 
    December 30, 2007     March 30, 2008  
    Gross     Accumulated     Net     Gross     Accumulated     Net  
    Assets     Amortization     Assets     Assets     Amortization     Assets  
Tradenames
  $ 7,700     $ (3,758 )   $ 3,942     $ 7,700     $ (4,033 )   $ 3,667  
Technology and intellectual property
    32,000       (10,933 )     21,067       32,000       (11,733 )     20,267  
Customer relationships
    99,300       (99,300 )           99,300       (99,300 )      
Software, licenses and others
    31,469       (15,724 )     15,745       34,122       (16,810 )     17,312  
 
                                   
 
  $ 170,469     $ (129,715 )   $ 40,754     $ 173,122     $ (131,876 )   $ 41,246  
 
                                   

 


 

     Amortization expense related to finite-lived intangible assets is summarized as follows (in thousands):
                 
    Three Months Ended  
    April 1,     March 30,  
    2007     2008  
Tradenames
  $ 275     $ 275  
Technology and intellectual property
    800       800  
Customer relationships
           
Software, licenses and others
    737       948  
 
           
 
  $ 1,812     $ 2,023  
 
           
     Finite-lived intangible assets are generally amortized over estimated useful lives of two to ten years. Estimated future amortization expense is summarized as follows (in thousands):
         
March 31, 2008 to December 28, 2008
  $ 6,282  
2009
    7,881  
2010
    6,013  
2011
    4,661  
2012
    3,886  
Thereafter
    12,523  
 
     
Total
  $ 41,246  
 
     
     The change in the carrying amount of goodwill for the three months ended March 30, 2008 is as follows (in thousands):
         
Balance as of December 31, 2007
  $ 547,958  
Purchase adjustment
    (2,618 )
 
     
Balance as of March 30, 2008
  $ 545,340  
 
     
     The purchase adjustment of $2.6 million relates to other tax liabilities recorded.
Note 3: Lines of Credit and Other Borrowings
     As of March 30, 2008, the Company’s total debt outstanding consisted of $648.0 million of borrowings, which included $150.0 million of the Company’s 7.5% Senior Notes due 2010, $215.0 million of the Company’s 6.75% Senior Notes due 2011, $3.7 million of the Company’s Zero Coupon Convertible Notes due 2008, $134.5 million of ChipPAC’s 2.5% Convertible Subordinated Notes due 2008, and other long-term and short-term borrowings.
     In January and February 2008, the Company repurchased $12.4 million and $2.5 million aggregate principal of its Zero Coupon Convertible Notes due 2008 for $14.7 million (including accrued interest) and $2.9 million (including accrued interest), respectively. The Company financed the repurchase of the $12.4 million and $2.5 million aggregate principal amount of these convertible notes with its cash and cash equivalents.
     In October 2007, the Company issued a $50.0 million promissory note carrying interest, payable annually, of 6% per annum to LSI Corporation (“LSI”) in connection with the acquisition of an assembly and test operations in Thailand. The amount payable to LSI after contractual netting of certain receivables from LSI of $3.2 million amounted to $46.8 million as of March 30, 2008. The promissory note is payable over four annual installments of $20.0 million, $10.0 million, $10.0 million and $6.8 million over the next four years.
     STATS ChipPAC Korea Ltd. has lines of credit with Hana Bank and the National Agricultural Cooperation Federation Bank in South Korea with credit limits of $10.0 million and $5.0 million, respectively. These lines of credit bear interest at a rate of 2.8% per annum on these facilities. As of March 30, 2008, the Company had not used these lines of credit and there was no outstanding balance on these facilities. These lines of credit are subject to an annual review by the lenders for the continued use of the facilities.
     STATS ChipPAC Korea Ltd. has a U.S. Dollar term loan facility of $25.0 million from Hana Bank. During 2006, STATS ChipPAC Korea Ltd. borrowed $12.0 million under this facility to finance its purchase of a building and land in South Korea. In 2007, STATS ChipPAC Korea Ltd. borrowed an additional $3.6 million under this facility.

 


 

As of March 30, 2008, the interest rate for the $12.0 million loan was 4.6% per annum and the interest rate for the $3.6 million loan was 4.4% per annum. The principal on the $12.0 million loan is repayable over eight equal quarterly installments from September 2007 to June 2009. The principal on the $3.6 million loan is repayable at maturity in June 2009. Interest is payable on a monthly basis. As of March 30, 2008, $0.6 million was held as a restricted deposit with the bank. These loans are secured by a pledge of land and a building with a combined net book value of $26.9 million as of March 30, 2008. As of March 30, 2008, $11.1 million of the loans was outstanding.
     STATS ChipPAC Taiwan Semiconductor Corporation has a NT$3.6 billion floating rate New Taiwan dollar term loan facility (approximately $119.9 million as of March 30, 2008) with a syndicate of lenders, with Taishin Bank as the sponsor bank. The loan drawdowns must be made within 24 months from the date of first drawdown which took place on February 18, 2007. As of March 30, 2008, STATS ChipPAC Taiwan Semiconductor Corporation has drawn down NT$0.7 billion (approximately $23.3 million as of March 30, 2008) under the term loan facility. As of March 30, 2007, the interest rate on the loan was 3.6% per annum. The principal and interest on the loan is payable in nine quarterly installments commencing 24 months from first draw down date with first eight quarterly installments each repaying 11% of the principal and the last quarterly installment repaying 12% of the principal. As of March 30, 2008, the outstanding balance on this facility was $23.3 million.
     Additionally, STATS ChipPAC Taiwan Semiconductor Corporation has NT$1.4 billion (approximately $45.6 million as of March 30, 2008) of bank and credit facilities from various other banks and financial institutions, of which $12.8 million borrowings was outstanding as of March 30, 2008. These credit facilities have varying interest rates ranging from 2.5% to 4.0% per annum and maturities ranging from 2008 through 2012.
     The Company has a $50.0 million line of credit with Bank of America. The loan bears an interest rate of 3.9% per annum. As of March 30, 2008, $50.0 million was borrowed against this facility. The principal and interest are payable at maturity in April 2008. The Company has the option to roll-forward the principal at maturity for a period of 1, 2, 3, or 6 months.
     The Company established a syndicated three-year revolving line of credit of $125.0 million in 2006. This line of credit was arranged by Oversea-Chinese Banking Corporation Limited and includes a total of six lenders. The facility is irrevocable by the bank syndicate for the three-year period unless the Company is in breach of its covenants, including minimum tangible assets, interest coverage ratios and debt ratios, or an event of default occurs, such as a failure to pay any amount due under the line of credit. The Company cancelled the revolving line of credit on January 31, 2008.
     At March 30, 2008, the Company had other undrawn banking and credit facilities consisting of long-term loans and bank guarantees of $34.0 million with financial institutions.
Note 4: Income Taxes
     Changes in share ownership by shareholder may result in a limitation on the amount of the Singapore net operating losses and unutilized capital allowances that are available as carryforwards for use by the Company. The Company reviewed the tax effect of such a shareholder change in connection with the tender offer by STSPL in 2007. In January 2008, the Singapore tax authorities confirmed that the limitations relating to the Company’s ability to carryforward of certain Singapore tax losses and capital allowances for offset against future taxable profits of the Company in connection with the tender offer by STSPL were not affected subject to the fulfillment of certain continuing conditions.
     In the three months ended March 30, 2008, approximately $3.0 million have been further reserved as liability on unrecognized tax benefits for uncertain tax positions and is accounted for as a current income tax adjustment due to an increase of the current period activity related to uncertain tax positions. In addition, the Company reclassed certain tax liabilities from deferred tax liabilities to liability for unrecognized tax benefits. As of March 30, 2008, the Company has approximately $11.7 million of such accrued interest and penalties.
     The Company is under tax examination in certain of these jurisdictions and is engaged with the South Korean National Tax Service (the “NTS”) through a Mutual Agreement Procedure (“MAP”) relating to withholding tax not collected on the interest income on the loan from ChipPAC’s Hungarian subsidiary to its South Korean subsidiary for the period from 1999 to May 2002. Refer to Note 6 for details.

 


 

Note 5: Earnings Per Share
     Basic earnings per share (“EPS”) is computed using the weighted average number of ordinary shares outstanding. Diluted EPS is computed using the weighted average number of ordinary shares outstanding and dilutive potential ordinary shares from the assumed exercise of share options outstanding during the period, if any, using the treasury stock method plus other potentially dilutive securities outstanding, such as convertible notes.
     The Company excluded certain potentially dilutive securities for each period presented from its diluted earnings per share computation because the exercise price of the securities exceeded the average fair value of the Company’s ordinary shares, and therefore these securities were anti-dilutive.
     A summary of the excluded potentially dilutive securities outstanding as of April 1, 2007 and March 30, 2008 follows (in thousands):
                 
    Three Months Ended
    April 1,   March 30,
    2007   2008
Convertible notes
    65,618       2,111  
Share plans
    42,772       15,364  
     The following is a reconciliation of the numerators and denominators of the basic and diluted EPS computations for the periods presented below (in thousands):
                 
    Three Months Ended  
    April 1,     March 30,  
    2007     2008  
Net income
  $ 17,047     $ 17,853  
 
               
Adjusted net income
  $ 17,610     $ 18,357  
 
               
Weighted average number of ordinary shares outstanding (basic)
    2,009,832       2,052,159  
Weighted average dilutive shares from share plans
    20,057       4,843  
Weighted average dilutive convertible notes
    161,871       145,144  
 
           
Weighted average number of ordinary and equivalent ordinary shares outstanding (diluted)
    2,191,760       2,202,146  
 
           
Note 6: Contingent Liabilities
     The Company is subject to claims and litigations, which arise in the normal course of business. These claims may include allegations of infringement of intellectual property rights of others as well as other claims of liability. The Company accrues liability associated with these claims and litigations when they are probable and reasonably estimable.
     In February 2006, the Company, ChipPAC and STATS ChipPAC (BVI) Limited were named as defendants in a patent infringement lawsuit filed in United States Federal Court for the Northern District of California (the “California Litigation”). The plaintiff, Tessera Technologies, Inc. (“Tessera”), has asserted that semiconductor chip packaging, specifically devices having Ball Grid Array (“BGA”) and multi-chip BGA configurations used by the defendants infringe certain patents of Tessera. Tessera has further asserted that the Company is in breach of an existing license agreement entered into by Tessera with ChipPAC, which agreement has been assigned by ChipPAC to the Company.
     In May 2007, at Tessera’s request, the United States International Trade Commission (the “ITC”) instituted an investigation of certain of the Company’s co-defendants in the California Litigation and other companies, including certain of the Company’s customers (the “First ITC Investigation”). In addition, in April 2007, Tessera instituted an action in Federal District Court for the Eastern District of Texas against certain of the Company’s co-defendants in the California Litigation and other companies (the “Texas Action”). In the First ITC Investigation, Tessera seeks an order preventing the named companies from importing certain packaged semiconductor chips and products containing them into the United States. The Texas Action seeks damages and injunctive relief against the named defendants. Both the First ITC Investigation and the Texas Action allege infringement of two of the same patents asserted by Tessera in the California Litigation, and may involve some of the same products packaged by the Company that are included in the California Litigation.

 


 

     In January 2008, Tessera served on the Company a draft complaint that Tessera proposed to file with the ITC to request an investigation (the “Proposed Second ITC Investigation”) of the Company and other semiconductor package assembly service providers that are defendants in the California Litigation. On January 30, 2008, the Company filed a motion with the ITC seeking leave to intervene in the First ITC Investigation for the limited purpose of seeking to postpone the hearing date in the First ITC Investigation and extend the target date for the completion of the First ITC Investigation in order to seek consolidation with the Proposed Second ITC Investigation if and when Tessera actually filed the complaint and the Proposed Second ITC Investigation is initiated.
     In February 2008, the district court presiding over the California Litigation held that Tessera may file the draft complaint requesting the Proposed Second ITC Investigation with the ITC. In April 2008, Tessera filed the complaint with the ITC. The ITC has not yet decided whether to initiate the Proposed Second ITC Investigation. In the Proposed Second ITC Investigation, Tessera seeks an order to prevent the Company and other named companies from providing packaging or assembly services for certain packaged semiconductor chips incorporating small format non-tape BGA semiconductor packages and products containing them, for importation into the United States. The Proposed Second ITC Investigation alleges infringement of three of the same patents asserted by Tessera in the California Litigation.
     The district court in the California Litigation has vacated the trial schedule and stayed all proceedings pending a final resolution of the First ITC Investigation. The United States Patent and Trademark Office has also instituted reexamination proceedings on all of the patents Tessera has asserted in the California Litigation and the Proposed Second ITC Investigation. In February 2008, the First ITC Investigation was stayed pending the outcome of the United States Patent and Trademark Office’s reexamination proceedings; however, such stay was lifted in March 2008. It is not possible to predict the outcome of the California Litigation or the Proposed Second ITC Investigation, the total costs of resolving the California Litigation and the Proposed Second ITC Investigation, or when the stay in the California Litigation will be lifted; nor is it possible to predict the outcome of the First ITC Investigation or the Texas Action. Nor is it possible to predict the outcome of the Patent and Trademark Office proceedings or their impact on the California Litigation, the First ITC Investigation and the Proposed Second ITC Investigation.
     The Company believes that it has a meritorious defense to these claims and intends to defend the lawsuit(s) vigorously. A court or ITC determination that the Company’s provision of certain semiconductor assembly services may infringe the intellectual property rights of others could result in significant liability and/or require the Company to make material changes to its provision of such assembly services. Due to the inherent uncertainties of the lawsuit(s) and investigation(s), the Company cannot accurately predict the ultimate outcome and it could result in significant liability and/or injunction and could have a material adverse effect on the business, financial condition and the results of operations of the Company.
     In addition, the Company is subject to various taxes in the different jurisdictions in which it operates. These include taxes on income, property, goods and services, and other taxes. The Company submits tax returns and claims with the appropriate government taxing authorities, which are subject to examination and agreement by those taxing authorities. The Company will regularly assess the likelihood of adverse outcomes resulting from these examinations to determine adequacy of provision for taxes.
     In connection with the merger of STATS and ChipPAC, the Company assumed certain contingent liabilities. In 2002, an assessment of approximately 16.0 billion South Korean Won (approximately $16.2 million based on the exchange rate as of March 30, 2008) was made by the South Korean National Tax Service (the “NTS”), relating to withholding tax not collected on the interest income on the loan from ChipPAC’s Hungarian subsidiary to its South Korean subsidiary for the period from 1999 to September 2001. The Company does not believe that the prevailing tax treaty requires withholding tax on the transaction in question. ChipPAC has appealed this assessment through the NTS’s Mutual Agreement Procedure (“MAP”). In July 2002, the Icheon tax office of the NTS approved a suspension of the proposed assessment until resolution of the disputed assessment. The NTS required a corporate guarantee amounting to the tax assessment in exchange for the suspension. ChipPAC complied with the guarantee request in July 2002. A further assessment of 2.7 billion South Korean Won (approximately $2.7 million based on the exchange rate as of March 30, 2008) was made against ChipPAC in January 2004 for interest expense from October 2001 to May 2002. ChipPAC engaged in a MAP and obtained suspension of the additional proposed assessment by providing a corporate guarantee in the amount of the additional assessment. The MAP was due to terminate on July 3, 2007 if not extended by the NTS. Prior to the termination, NTS extended the MAP on June 4, 2007. Based on South Korean tax law, the extension period should not exceed three years. In the event that the Company is not successful with its appeal, the Company estimates that the maximum amount payable by the Company, including potential interest and local surtax, as of March 30, 2008 to be 33.5 billion South Korean Won (approximately $33.8 million based on the exchange rate as of March 30, 2008). The final outcome of the resolution of this matter could result in significant liability and could have a material adverse effect on the business, financial condition and results of operations of the Company.

 


 

Note 7: Condensed Consolidating Financial Information
In connection with the merger with ChipPAC in 2004, the Company assumed the $150.0 million 2.5% Convertible Subordinated Notes due 2008, of which $134.5 million principal amount were outstanding as of March 30, 2008, issued by ChipPAC. In October 2004, in connection with the filing of the prospectus to register the resale of the Convertible Notes issued by ChipPAC, the Company, but not any of its direct or indirect subsidiaries, provided a full and unconditional guarantee of the Convertible Notes on a subordinated basis.
In November 2004, the Company issued $215.0 million of 6.75% Senior Notes due 2011. These senior notes issued by STATS ChipPAC are fully and unconditionally guaranteed, jointly and severally, on a senior basis, by the following wholly owned subsidiaries: (1) STATS ChipPAC, Inc., (2) STATS ChipPAC (Barbados) Ltd., STATS ChipPAC (BVI) Limited, ChipPAC International Company Limited, STATS ChipPAC Malaysia Sdn. Bhd., STATS ChipPAC (Thailand) Limited, STATS ChipPAC Test Services, Inc., STATS Holdings Limited, ChipPAC Luxembourg S.a.R.L., ChipPAC Liquidity Management Hungary Limited Liability Company, and STATS ChipPAC Taiwan Co., Ltd. (the “Guarantor Subsidiaries”) and (3) STATS ChipPAC Korea Ltd. STATS ChipPAC Shanghai Co., Ltd., STATS ChipPAC Test Services (Shanghai) Co., Ltd., STATS ChipPAC Semiconductor Shanghai Co., Ltd. and STATS ChipPAC Taiwan Semiconductor Corporation (the “Non-Guarantor Subsidiaries”) did not provide guarantees.
In July 2005, the Company issued $150.0 million of 7.5% Senior Notes due 2010. These senior notes are fully and unconditionally guaranteed, jointly and severally, on a senior basis, by STATS ChipPAC, Inc. and the Guarantor Subsidiaries. The Non-Guarantor Subsidiaries and STATS ChipPAC Korea Ltd. did not provide guarantees.
The following is the consolidated financial information segregated between STATS ChipPAC Ltd. as the parent company and guarantor of the $134.5 million 2.5% Convertible Subordinated Notes and issuer of the $215.0 million 6.75% Senior Notes due 2011 and the $150.0 million 7.5% Senior Notes due 2010; STATS ChipPAC, Inc. as issuer of the $134.5 million 2.5% Convertible Subordinated Notes and a guarantor of the $215.0 million 6.75% Senior Notes due 2011 and the $150.0 million 7.5% Senior Notes due 2010; STATS ChipPAC Korea Ltd. as a guarantor of the $215.0 million 6.75% Senior Notes due 2011 and non-guarantor of the $150.0 million 7.5% Senior Notes due 2010; the other Guarantor Subsidiaries and other Non-Guarantor Subsidiaries of the $215.0 million 6.75% Senior Notes due 2011 and the $150.0 million 7.5% Senior Notes due 2010.

 


 

STATS CHIPPAC LTD. AND SUBSIDIARIES
CONDENSED CONSOLIDATING BALANCE SHEETS
As of December 30, 2007
In thousands of U.S. Dollars
(Unaudited)
                                                         
    STATS     STATS     STATS             Non -              
    ChipPAC     ChipPAC,     ChipPAC     Guarantor     Guarantor              
    Ltd.     Inc.     Korea     Subsidiaries     Subsidiaries     Eliminations     Consolidated  
ASSETS
                                                       
Current assets:
                                                       
Cash and cash equivalents
  $ 91,813     $ 793     $ 25,224     $ 65,152     $ 30,479     $     $ 213,461  
Short-term marketable securities
                            29,230             29,230  
Accounts receivable, net
    72,827                   183,486       15,047             271,360  
Amounts due from affiliates
    440,518       143,154       38,005       142,288       65,932       (820,605 )     9,292  
Other receivables
    2,527       195       2,716       709       730             6,877  
Inventories
    19,614             38,516       11,680       13,502             83,312  
Prepaid expenses and other current assets
    5,276       575       2,589       10,595       3,285             22,320  
 
                                         
Total current assets
    632,575       144,717       107,050       413,910       158,205       (820,605 )   $ 635,852  
Long-term marketable securities
    15,296                                     15,296  
Long-term amounts due from affiliates
                            6,852             6,852  
Property, plant and equipment, net
    280,371       3,853       382,420       285,975       323,871             1,276,490  
Investment in equity investee
    10,350                                     10,350  
Investment in subsidiaries
    995,948       14,968             111,167             (1,122,083 )      
Intangible assets
    5,646       2,044       1,586       28,451       3,027             40,754  
Goodwill
                316,067       125,800       103,882       2,209       547,958  
Long-term restricted cash
                629       614       369             1,612  
Prepaid expenses and other non-current assets
    15,055       144       27,061       1,262       18,268             61,790  
 
                                         
Total assets
  $ 1,955,241     $ 165,726     $ 834,813     $ 967,179     $ 614,474     $ (1,940,479 )   $ 2,596,954  
 
                                         
LIABILITIES AND SHAREHOLDERS’ EQUITY
                                                       
Current liabilities:
                                                       
Accounts and other payables
  $ 14,024     $ 269     $ 76,254     $ 28,511     $ 45,242     $     $ 164,300  
Payables related to property, plant and equipment purchases
    13,422             35,486       11,350       10,486             70,744  
Accrued operating expenses
    48,028       8,589       12,091       28,965       11,843             109,516  
Income taxes payable
          68       7,682       2,650       6,850             17,250  
Short-term borrowings
    50,000                         300             50,300  
Amounts due to affiliates
    58,447       6,332       87,560       622,577       47,340       (820,605 )     1,651  
Current obligations under capital leases
                                         
Current installments of long-term debts
    21,991       134,500       6,000       20,000       7,990             190,481  
 
                                         
Total current liabilities
    205,912       149,758     $ 225,073     $ 714,053     $ 130,051       (820,605 )   $ 604,242  
Long-term debts, excluding current installments
    365,000             6,600       26,800       25,453             423,853  
Other non-current liabilities
    360             95,377       19,067       10,289             125,093  
 
                                         
Total liabilities
    571,272       149,758       327,050       759,920       165,793       (820,605 )     1,153,188  
 
                                         
Minority interest
                                  59,797       59,797  
Total shareholders’ equity
    1,383,969       15,968       507,763       207,259       448,681       (1,179,671 )     1,383,969  
 
                                         
Total liabilities and shareholders’ equity
  $ 1,955,241     $ 165,726     $ 834,813     $ 967,179     $ 614,474     $ (1,940,479 )   $ 2,596,954  
 
                                         

 


 

STATS CHIPPAC LTD. AND SUBSIDIARIES
CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS
For the Three Months Ended April 1, 2007
In thousands of U.S. Dollars
(Unaudited)
                                                         
                    STATS             Non -              
    STATS             ChipPAC     Guarantor     Guarantor              
    ChipPAC     ChipPAC     Korea     Subsidiaries     Subsidiaries     Eliminations     Consolidated  
 
Net revenues
  $ 105,248     $ 8,913     $ 148,410     $ 279,570     $ 81,515     $ (233,186 )   $ 390,470  
Cost of revenues
    82,141             123,779       254,870       67,637       (215,516 )     312,911  
 
                                         
Gross profit
    23,107       8,913       24,631       24,700       13,878       (17,670 )     77,559  
 
                                         
Operating expenses:
                                                       
Selling, general and administrative
    14,970       6,567       3,358       15,763       1,829       (14,488 )     27,999  
Research and development
    2,987       1,523       2,540       4,011       313       (3,189 )     8,185  
Tender offer expenses
    6,808                                     6,808  
 
                                         
Total operating expenses
    24,765       8,090       5,898       19,774       2,142       (17,677 )     42,992  
 
                                         
Operating income (loss)
    (1,658 )     823       18,733       4,926       11,736       7       34,567  
 
                                         
Other income (expense), net:
                                                       
Interest income
    910             185       1,036       214       (508 )     1,837  
Interest expense
    (8,802 )     (962 )     (787 )           (421 )     508       (10,464 )
Foreign currency exchange gain (loss)
    14             368       (358 )     96             120  
Equity loss from equity investee
    (253 )                                   (253 )
Equity income from investment in subsidiaries
    28,454       61             7,910             (36,425 )      
Other non-operating income (expense), net
    (113 )     (15 )           53       116             41  
 
                                         
Total other income (expense), net
    20,210       (916 )     (234 )     8,641       5       (36,425 )     (8,719 )
 
                                         
Income (loss) before income taxes
    18,552       (93 )     18,499       13,567       11,741       (36,418 )     25,848  
Income tax expense
    (1,505 )     (49 )     (3,824 )     (642 )     (1,631 )           (7,651 )
 
                                         
Income (loss) before minority interest
    17,047       (142 )     14,675       12,925       10,110       (36,418 )     18,197  
Minority interest
                                  (1,150 )     (1,150 )
 
                                         
Net income (loss)
  $ 17,047     $ (142 )   $ 14,675     $ 12,925     $ 10,110     $ (37,568 )   $ 17,047  
 
                                         

 


 

STATS CHIPPAC LTD. AND SUBSIDIARIES
CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS
For the Three Months Ended April 1, 2007
In thousands of U.S. Dollars
(Unaudited)
                                                         
                    STATS             Non -              
    STATS             ChipPAC     Guarantor     Guarantor              
    ChipPAC     ChipPAC     Korea     Subsidiaries     Subsidiaries     Eliminations     Consolidated  
 
                                                       
Cash Flows From Operating Activities
                                                       
Net income (loss)
  $ 17,047     $ (142 )   $ 14,675     $ 12,925     $ 10,110     $ (37,568 )   $ 17,047  
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
                                                       
Depreciation and amortization
    21,646       219       14,430       12,488       12,003       (7 )     60,779  
Amortization of leasing prepayments
    11                                     11  
Debt issuance cost amortization
    591       27                               618  
Loss (gain) on sale of property, plant and equipment
    1,065             (1 )     (8 )     (331 )           725  
Accretion of discount on convertible notes
    1,386                                     1,386  
Foreign currency exchange (gain) loss
    (35 )                       (337 )           (372 )
Share-based compensation expense
    920       393       1,298       314       (43 )           2,882  
Deferred income taxes
    1,505             3,824       306       187             5,822  
Minority interest in income of subsidiary
                                  1,150       1,150  
Equity income from investment in subsidiaries
    (28,454 )     (61 )           (7,910 )           36,425        
Equity loss from investment in equity investee
    253                                     253  
Gain on sale of marketable securities
                            (72 )           (72 )
Others
                (42 )     39       55             52  
Changes in operating working capital:
                                                       
Accounts receivable
    8,644                   (7,684 )     54             1,014  
Amounts due from affiliates
    17,495       (29 )     (4,518 )     (8,188 )     528       (5,278 )     10  
Inventories
    7,747             3,901       119       2,739             14,506  
Other receivables, prepaid expenses and other assets
    1,789       (17 )     1,875       368       134             4,149  
Accounts payable, accrued operating expenses and other payables
    (10,775 )     (1,451 )     (11,662 )     (162 )     (10,063 )           (34,113 )
Amounts due to affiliates
    896       1,212       7,268       (17,476 )     2,794       5,278       (28 )
 
                                         
Net cash provided by operating activities
    41,731       151       31,048       (14,869 )     17,758             75,819  
 
                                         
Cash Flows From Investing Activities
                                                       
Proceeds from sales of marketable securities
  $     $     $     $     $ 10,327     $     $ 10,327  
Proceeds from maturity of marketable securities
                            2,946             2,946  
Cash injection in subsidiary
    (673 )                             673        
Acquisition of intangible assets
    (296 )                 (208 )     (110 )           (614 )
Purchases of property, plant and equipment
    (11,039 )     (50 )     (36,234 )     (7,930 )     (10,101 )     9,564       (55,790 )
Others, net
    6,556             489       1,061       4,661       (9,564 )     3,203  
 
                                         
Net cash used in investing activities
    (5,452 )     (50 )     (35,745 )     (7,077 )     7,723       673       (39,928 )
 
                                         
Cash Flows From Financing Activities
                                                       
Repayment of short-term debts
  $     $     $     $     $ (544 )   $     $ (544 )
Repayment of long-term debts
                (690 )           (38,036 )           (38,726 )
Proceeds from issuance of shares, net of expenses
    11,069                         673       (673 )     11,069  
Repurchase and redemption of senior and convertible notes
    (36,800 )                                   (36,800 )
Proceeds from bank borrowings
                            15,548             15,548  
Decrease in restricted cash
                            4             4  
Capital lease payments
                (1,823 )                       (1,823 )
 
                                         
Net cash provided by (used in) financing activities
    (25,731 )           (2,513 )           (22,355 )     (673 )     (51,272 )
 
                                         
Net increase (decrease) in cash and cash equivalents
    10,548       101       (7,210 )     (21,946 )     3,126             (15,381 )
Effect of exchange rate changes on cash and cash equivalents
                            102             102  
Cash and cash equivalents at beginning of the period
    69,057       177       22,503       55,608       24,112             171,457  
 
                                         
Cash and cash equivalents at end of the period
  $ 79,605     $ 278     $ 15,293     $ 33,662     $ 27,340     $     $ 156,178  
 
                                         

 


 

STATS CHIPPAC LTD. AND SUBSIDIARIES
CONDENSED CONSOLIDATING BALANCE SHEETS
As of March 30, 2008
In thousands of U.S. Dollars
(Unaudited)
                                                         
    STATS     STATS     STATS             Non -              
    ChipPAC     ChipPAC,     ChipPAC     Guarantor     Guarantor              
    Ltd.     Inc.     Korea     Subsidiaries     Subsidiaries     Eliminations     Consolidated  
ASSETS
                                                       
Current assets:
                                                       
Cash and cash equivalents
  $ 97,294     $ 1,149     $ 26,497     $ 49,784     $ 35,026     $     $ 209,750  
Short-term marketable securities
                      3,810       49,324             53,134  
Accounts receivable, net
    75,062                   176,266       13,019             264,347  
Amounts due from affiliates
    446,383       139,265       10,768       159,622       47,820       (795,100 )     8,758  
Other receivables
    2,417       207       6,452       3,478       1,149             13,703  
Inventories
    19,140             43,174       9,977       11,214             83,505  
Prepaid expenses and other current assets
    9,222       461       2,380       7,404       1,523             20,990  
 
                                         
Total current assets
    649,518       141,082       89,271       410,341       159,075       (795,100 )     654,187  
Long-term marketable securities
    15,809                                     15,809  
Long-term amounts due from affiliates
                            9,635             9,635  
Property, plant and equipment, net
    265,366       3,758       394,791       278,201       329,062             1,271,178  
Investment in equity investee
    10,257                                     10,257  
Investment in subsidiaries
    1,017,787       14,974             110,797             (1,143,558 )      
Intangible assets
    7,385       2,098       1,480       27,401       2,882             41,246  
Goodwill
                313,449       125,800       103,882       2,209       545,340  
Long-term restricted cash
                636       659       400             1,695  
Prepaid expenses and other non-current assets
    13,433       98       24,577       1,352       15,289             54,749  
 
                                         
Total assets
  $ 1,979,555     $ 162,010     $ 824,204     $ 954,551     $ 620,225     $ (1,936,449 )   $ 2,604,096  
 
                                         
LIABILITIES AND SHAREHOLDERS’ EQUITY
                                                       
Current liabilities:
                                                       
Accounts and other payables
  $ 14,777     $ 237     $ 87,509     $ 28,782     $ 40,804     $     $ 172,109  
Payables related to property, plant and equipment purchases
    11,163             31,712       6,135       5,723             54,733  
Accrued operating expenses
    44,210       7,159       28,227       24,079       12,767             116,442  
Income taxes payable
          158       5,646       3,941       2,680             12,425  
Short-term borrowings
    50,000                         300             50,300  
Amounts due to affiliates
    70,966       3,792       71,064       605,732       45,056       (795,100 )     1,510  
Current installments of long-term debts
    4,452       134,500       6,000       20,000       11,096             176,048  
 
                                         
Total current liabilities
    195,568       145,846       230,158       688,669       118,426       (795,100 )     583,567  
Long-term debts, excluding current installments
    365,000             5,100       26,800       24,716             421,616  
Other non-current liabilities
    2,903             79,368       19,912       14,452             116,635  
 
                                         
Total liabilities
    563,471       145,846       314,626       735,381       157,594       (795,100 )     1,121,818  
 
                                         
Minority interest
                                  66,194       66,194  
Total shareholders’ equity
    1,416,084       16,164       509,578       219,170       462,631       (1,207,543 )     1,416,084  
 
                                         
Total liabilities and shareholders’ equity
  $ 1,979,555     $ 162,010     $ 824,204     $ 954,551     $ 620,225     $ (1,936,449 )   $ 2,604,096  
 
                                         

 


 

STATS CHIPPAC LTD. AND SUBSIDIARIES
CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS
For the Three Months Ended March 30, 2008
In thousands of U.S. Dollars
(Unaudited)
                                                         
                    STATS             Non -              
    STATS             ChipPAC     Guarantor     Guarantor              
    ChipPAC     ChipPAC     Korea     Subsidiaries     Subsidiaries     Eliminations     Consolidated  
 
                                                       
Net revenues
  $ 107,938     $ 9,117     $ 152,514     $ 313,333     $ 69,377     $ (225,037 )   $ 427,242  
Cost of revenues
    80,292             138,250       278,135       62,701       (206,674 )     352,704  
 
                                         
Gross profit
    27,646       9,117       14,264       35,198       6,676       (18,363 )     74,538  
 
                                         
Operating expenses:
                                                       
Selling, general and administrative
    15,663       6,673       3,708       16,934       2,649       (14,161 )     31,466  
Research and development
    4,393       1,356       2,770       5,186       508       (4,208 )     10,005  
Restructuring charges
                      900                   900  
 
                                         
Total operating expenses
    20,056       8,029       6,478       23,020       3,157       (18,369 )     42,371  
 
                                         
Operating income
    7,590       1,088       7,786       12,178       3,519       6       32,167  
 
                                         
Other income (expense), net:
                                                       
Interest income
    685       1       57       862       338       (508 )     1,435  
Interest expense
    (8,494 )     (868 )     (695 )     (738 )     (255 )     508       (10,542 )
Foreign currency exchange gain (loss)
    1,108       (1 )     2,136       805       (840 )           3,208  
Equity loss from equity investee
    (136 )                                   (136 )
Equity income from investment in subsidiaries
    17,120       5             (371 )           (16,754 )      
Other non-operating income (expense), net
    (20 )     (16 )           682       82             728  
 
                                         
Total other income (expense), net
    10,263       (879 )     1,498       1,240       (675 )     (16,754 )     (5,307 )
 
                                         
Income before income taxes
    17,853       209       9,284       13,418       2,844       (16,748 )     26,860  
Income tax expense
          124       5,236       1,786       474             7,620  
 
                                         
Income before minority interest
    17,853       85       4,048       11,632       2,370       (16,748 )     19,240  
Minority interest
                                  (1,387 )     (1,387 )
 
                                         
Net income
  $ 17,853     $ 85     $ 4,048     $ 11,632     $ 2,370     $ (18,135 )   $ 17,853  
 
                                         

 


 

STATS CHIPPAC LTD. AND SUBSIDIARIES
CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS
For the Three Months Ended March 30, 2008
In thousands of U.S. Dollars
(Unaudited)
                                                         
                    STATS             Non -              
    STATS             ChipPAC     Guarantor     Guarantor              
    ChipPAC     ChipPAC     Korea     Subsidiaries     Subsidiaries     Eliminations     Consolidated  
 
                                                       
Cash Flows From Operating Activities
                                                       
Net income (loss)
    17,853       85       4,048       11,632       2,370       (18,135 )     17,853  
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
                                                       
Depreciation and amortization
    20,572       241       19,505       17,464       13,002             70,784  
Debt issuance cost amortization
    1,449       30                               1,479  
Loss (gain) on sale of property, plant and equipment
    (42 )                 (1 )     (221 )           (264 )
Accretion of discount on convertible notes
    31                                     31  
Foreign currency exchange (gain) loss
                            1,514             1,514  
Share-based compensation expense
    518       111       475       60       76             1,240  
Deferred income taxes
                1,990       312       (330 )           1,972  
Minority interest in income of subsidiary
                                  1,387       1,387  
Equity income from investment in subsidiaries
    (17,120 )     (5 )           371             16,754        
Equity loss from investment in equity investee
    136                                     136  
Gain on sale of marketable securities
                            (8 )           (8 )
Others
    7             8       3       51             69  
Changes in operating working capital:
                                                       
Accounts receivable
    (2,235 )                 7,220       2,028             7,013  
Amounts due from affiliates
    (5,865 )     3,889       27,237       (17,334 )     15,329       (25,505 )     (2,249 )
Inventories
    474             (4,658 )     1,703       2,288             (193 )
Other receivables, prepaid expenses and other assets
    (317 )     118       (6,124 )     (3,375 )     1,267             (8,431 )
Accounts payable, accrued operating expenses and other payables
    (518 )     (1,372 )     12,348       (2,840 )     (2,868 )     (6 )     4,744  
Amounts due to affiliates
    12,519       (2,540 )     (16,496 )     (16,845 )     (2,284 )     25,505       (141 )
 
                                         
Net cash provided by operating activities
    27,462       557       38,333       (1,630 )     32,214             96,936  
 
                                         
Cash Flows From Investing Activities
                                                       
Proceeds from sales of marketable securities
  $     $     $     $     $ 7,473     $     $ 7,473  
Proceeds from maturity of marketable securities
                            4,589             4,589  
Purchases of marketable securities
                      (3,810 )     (29,098 )           (32,908 )
Cash injection in subsidiary
    (1,031 )                             1,031        
Acquisition of intangible assets
    (1,811 )     (163 )     (116 )     (253 )     (2 )           (2,345 )
Purchases of property, plant and equipment
    (10,668 )     (38 )     (36,656 )     (17,573 )     (15,355 )     9,063       (71,227 )
Proceeds on assets held for sale
                      3,978       2,783             6,761  
Others, net
    2,950             1,219       3,964       1,329       (9,063 )     399  
 
                                         
Net cash used in investing activities
    (10,560 )     (201 )     (35,553 )     (13,694 )     (28,281 )     1,031       (87,258 )
 
                                         
Cash Flows From Financing Activities
                                                       
Repayment of long-term debts
  $     $     $ (1,500 )   $     $ (384 )   $     $ (1,884 )
Proceeds from issuance of shares, net of expenses
    6,150                         1,031       (1,031 )     6,150  
Repurchase and redemption of senior and convertible notes
    (17,571 )                                   (17,571 )
Increase in restricted cash
                (7 )     (44 )     (30 )           (81 )
 
                                         
Net cash provided by (used in) financing activities
    (11,421 )           (1,507 )     (44 )     617       (1,031 )     (13,386 )
 
                                         
Net increase (decrease) in cash and cash equivalents
    5,481       356       1,273       (15,368 )     4,550             (3,708 )
Effect of exchange rate changes on cash and cash equivalents
                            (3 )           (3 )
Cash and cash equivalents at beginning of the period
    91,813       793       25,224       65,152       30,479             213,461  
 
                                         
Cash and cash equivalents at end of the period
  $ 97,294     $ 1,149     $ 26,497     $ 49,784     $ 35,026     $     $ 209,750  
 
                                         

 


 

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
     The following discussion of our business, financial condition and results of operations should be read in conjunction with our unaudited condensed consolidated financial statements and the related notes included in this report. This discussion contains forward-looking statements that reflect our current views with respect to future events and financial performance. Our actual results may differ from those anticipated in these forward looking statements as a result of certain factors, such as those set forth in our annual report on Form 20-F filed with the SEC on March 7, 2008. Since the beginning of fiscal 2005, we have employed quarterly and fiscal year reporting periods. Our 52-53 week fiscal year ends on the Sunday nearest and prior to December 31. Our fiscal quarters end on a Sunday and are generally thirteen weeks in length. Our first quarter of 2008 ended on March 30, 2008, while our first quarter of 2007 and fiscal year 2007 ended on April 1, 2007 and December 30, 2007, respecitvely. References to “$” are to the lawful currency of the United States of America. The noon buying rate in The City of New York on March 30, 2008 was 992.40 South Korean Won per $1.00 for cable transfers in South Korean Won and was 30.38 New Taiwan Dollar per $1.00 for cable transfers in New Taiwan Dollars, as certified for customs purposes by the Federal Reserve Bank of New York. For your convenience, unless otherwise indicated, certain South Korean Won and New Taiwan Dollar amounts have been translated into U.S. Dollar amounts based on these exchange rates.
Overview
     We are a leading service provider of semiconductor packaging design, bump, probe, assembly, test and distribution solutions. We have the scale to provide a comprehensive range of semiconductor packaging and test solutions to a diversified global customer base servicing the computing, communications, consumer, automotive and industrial markets. Our services include:
  Packaging services: providing leaded, power, array, memory card and wafer level chip-scale packages (“CSPs”) to customers with a broad range of packaging solutions and full backend turnkey services for a wide variety of electronics applications. We also provide redistribution layers, integrated passive devices and wafer bumping services for flip-chip and wafer level CSPs. As part of customer support on packaging services, we also offer package design; electrical, mechanical and thermal simulation; measurement and design of lead-frames and laminate substrates;
 
  Test services: including wafer probe and final testing on a diverse selection of test platforms covering the major test platforms in the industry. We have expertise in testing a broad variety of semiconductors, especially mixed-signal, radio frequency, analog and high-performance digital devices. We also offer test-related services such as burn-in process support, reliability testing, thermal and electrical characterization, dry pack, and tape and reel; and
 
  Pre-production and post-production services: such as package development, test software and related hardware development, warehousing and drop shipment services.
     We have a leadership position in providing advanced packages, such as stacked die, System-in-Package and flip-chip, as well as Ball Grid Array (“BGA”) packages and wafer level CSPs. We are a leader in high volume assembly, test and distribution of discrete and analog power packages.
     We are also a leader in testing mixed-signal semiconductors or semiconductors combining the use of analog and digital circuits in a chip. Mixed-signal semiconductors are used extensively in fast-growing communications and consumer applications. We have strong expertise in testing a wide range of high-performance digital devices.
     We have been successful in attracting new customers with our packaging and test capabilities and then expanding our relationship with such customers to provide full turnkey solutions tailored to their individual needs.
     We are headquartered in Singapore and our manufacturing facilities are strategically located in South Korea, Singapore, China, Malaysia, Taiwan (which includes our 52%-owned subsidiary, STATS ChipPAC Taiwan Semiconductor Corporation) and Thailand. We also have test pre-production facilities in the United States. We market our services through our direct sales force in the United States, South Korea, Japan, China, Singapore, Malaysia, Taiwan, the United Kingdom and the Netherlands. With an established presence in the countries where strategic semiconductor markets are located, we are in close proximity to the major hubs of wafer fabrication which allows us to provide customers with fully-integrated, multi-site, end-to-end packaging and test services.

 


 

Proposed Capital Reduction Exercise
     In January 2008, we announced our intention to effect a proposed capital reduction to return surplus share capital in an amount of up to $813.0 million to our shareholders. At an extraordinary general meeting held on March 17, 2008, our shareholders approved the proposed capital reduction. The proposed capital reduction is subject to and conditional upon us being able to obtain adequate debt financing to fund the cash distribution and the repayment of certain of our outstanding debt (including the redemption or repurchase of our 7.5% senior notes due 2010 and 6.75% senior notes due 2011 (“our senior notes”) that would otherwise restrict our ability to make the cash distribution and to finance the cash distribution) on terms and conditions acceptable to us. The amount of the cash distribution would accordingly be determined based on the proceeds of such debt financing made available to us. The proposed capital reduction is also subject to (1) approval by the Singapore High Court and other applicable regulatory authorities and (2) the board of directors determining, following the satisfaction of the preceding conditions, that it is in our best interest, to effect the proposed cash distribution.
Temasek’s Subsidiary, Singapore Technologies Semiconductors Pte Ltd’s, Tender Offer
     In March 2007, Singapore Technologies Semiconductors Pte Ltd (“STSPL”), a wholly-owned subsidiary of Temasek Holdings (Private) Limited (“Temasek”), launched a voluntary conditional cash tender offer for our ordinary shares and American Depositary Shares (“ADSs”) that STSPL did not already own. The tender offer also included an offer by STSPL for our then outstanding $115.0 million aggregate principal amount of zero coupon convertible notes due 2008 and $150.0 million aggregate principal amount of 2.50% convertible subordinated notes due 2008. Concurrently with the tender offer, STSPL made an options proposal to all holders of options granted under STATS ChipPAC share option plans.
     In May, 2007, the tender offer closed with STSPL and its concert parties holding 83.1% of our outstanding ordinary shares (including ordinary shares represented by ADSs, but excluding the ordinary shares issuable upon the potential conversion of the $134.5 million aggregate principal amount of the 2.5% convertible subordinated notes due 2008 acquired by STSPL) and $134.5 million aggregate principal amount of the 2.5% convertible subordinated notes due 2008. The balance $15.5 million outstanding principal amount of our 2.5% convertible subordinated notes due 2008 was converted into ADSs in May 2007.
     As of March 30, 2008, Temasek, through its wholly-owned subsidiary, STSPL, beneficially owned approximately 82.7% of the Company’s outstanding ordinary shares. As of March 30, 2008, STSPL (and through its ownership of STSPL, Temasek) beneficially owned 1,845,715,689 ordinary shares (including ordinary shares represented by ADSs and ordinary shares into which the $134.5 million aggregate principal amount of 2.5% convertible subordinated notes due 2008 beneficially owned by STSPL may be converted), representing 83.8% of the issued ordinary shares (including in the numerator and the denominator the ordinary shares issuable upon conversion of the 2.5% convertible subordinated notes due 2008 beneficially owned by STSPL).
     During the three and twelve months ended April 1, 2007 and December 30, 2007, respectively, we recorded tender offer expenses of $6.8 million and $10.9 million, consisting of investment banking, legal, accounting, insurance, printing and other costs associated with the tender offer. No tender offer expenses were incurred during the three months ended March 30, 2008.
Results of Operations
Three months ended March 30, 2008 compared to three months ended April 1, 2007
Net Revenues
     We derive revenues primarily from test and packaging of array and leaded packages. Net revenues were $427.2 million in the three months ended March 30, 2008, an increase of 9.4% compared to $390.5 million in the three months ended April 1, 2007. The increase in net revenues for the three months ended March 30, 2008 was primarily due to increased packaging revenue from higher unit volume and more favorable product mix, and contribution from our factory in Pathumthani, Thailand, which we acquired in October 2007.
     Our packaging revenues in the three months ended March 30, 2008 increased 6.7% to $314.8 million, compared to the same period in 2007. Unit volumes of our total packaging in the three months ended March 30, 2008 was 3.9% higher compared to the same period in 2007 and resulted in an increase of $14.1 million. Average selling prices per pin for packaging services in the three months ended March 30, 2008 increased 2.8%, compared to the same period in 2007. This was primarily due to favorable changes in product mix, which contributed to an increase in revenue by $5.8 million for the three months ended March 30, 2008. Revenues from test and other services in the three months ended March 30, 2008 increased 17.6% to $112.4 million, compared to the three months ended April 1, 2007.

 


 

     In the three months ended March 30, 2008, revenue contribution from the communications market increased 1.2% over the same period in 2007 and represented 53.7% of our revenues in the three months ended March 30, 2008, compared to 52.5% of our revenues in the same period in 2007. Revenue contribution from consumer, multi-applications and other markets in the three months ended March 30, 2008 decreased 1.1% compared to the same period in 2007 and represented 30.3% of our revenues in the three months ended March 30, 2008. Revenue contribution from the personal computers market in the three months ended March 30, 2008 decreased 0.1% over the same period in 2007 and represented 16.0% of our revenues in the three months ended March 30, 2008. We expect to continue to depend on the communications, consumer and multi-applications, and personal computer markets for substantially all of our net revenues.
Gross Profit
     Gross profit in the three months ended March 30, 2008 was $74.5 million, a decrease of $3.1 million compared to $77.6 million in the same period in 2007. Gross profit as a percentage of revenues was 17.4% in the three months ended March 30, 2008 compared to 19.9% in the same period in 2007. Gross profit in the three months ended March 30, 2008 and April 1, 2007 included $0.6 million and $1.5 million of share-based compensation expense related to share options and employee share purchase rights under SFAS 123(R), respectively, which reduced gross margin by 0.2% and 0.3% in the three months ended March 30, 2008 and April 1, 2007, respectively. In the three months ended March 30, 2008, gross profit decreased primarily due to lower equipment utilization, higher material cost, and Asian currencies appreciation against the U.S. Dollar, partially offset by the impact of favorable changes in product mix to our overall average selling prices. Overall equipment utilization was approximately 69% in the three months ended March 30, 2008 compared to approximately 75% in the same period in 2007. Our cost of revenues consist principally of fixed costs such as depreciation and leasing expenses and variable costs such as direct and indirect labor, materials and overhead expenses. We continue to experience higher cost as a result of external global economic factors, such as higher substrate, gold and oil prices which affected our cost of materials, and the adverse effect the strengthening of the Singapore Dollar, Chinese Renminbi and Malaysian Ringgit against the U.S. Dollar when compared to the same period in 2007.
Selling, General and Administrative
     Selling, general and administrative expenses were $31.5 million in the three months ended March 30, 2008, an increase of 12.4% compared to $28.0 million in the three months ended April 1, 2007. As a percentage of revenues, selling, general and administrative expenses were 7.4% in the three months ended March 30, 2008 compared to 7.2% in the same period in 2007. The increase in selling, general and administrative expenses in the three months ended March 30, 2008 was primarily due to higher payroll expense resulting from an increased number of employees and the Asian currencies appreciation against the U.S. Dollar, and increased cost of general business support. This was partially offset by lower Sarbanes-Oxley Act compliance related expenses and lower share-based compensation expense. In the three months ended March 30, 2008, share-based compensation expense under SFAS 123(R) was $0.5 million, compared to $1.1 million in the same period in 2007.
Research and Development
     Research and development expenses were $10.0 million in the three months ended March 30, 2008, an increase of $1.8 million, compared to $8.2 million in the same period in 2007. Research and development expenses increased primarily due to an increase in headcount and the establishment of a facility for the research and development of advanced wafer integration technology. As a percentage of revenues, research and development expenses were 2.3% in the three months ended March 30, 2008 compared to 2.1% in the same period in 2007.
Tender Offer Expenses
     In the three months ended April 1, 2007, we incurred $6.8 million consisting of investment banking, legal, accounting, insurance, printing and other costs associated with the tender offer from STSPL, a wholly-owned subsidiary of Temasek. No tender offer expenses were incurred in the three months ended March 30, 2008.
Restructuring Charges
     In the three months ended March 30, 2008, we reduced our workforce by 75 employees following the implementation of a restructuring plan to realign our organization’s structure and efficiency. Severance and related charges of $0.9 million were expensed during this period. No restructuring charges were incurred in the three months ended April 1, 2007.
Net Interest Income (Expense)
     Net interest expense was $9.1 million in the three months ended March 30, 2008 compared to $8.6 million in the same period in 2007. Interest income was $1.4 million in the three months ended March 30, 2008 compared to $1.8 million in the same period in 2007. The decrease in interest income in the three months ended March 30, 2008 was primarily due to lower interest rates compared to the same period in 2007.

 


 

     Interest expense was $10.5 million in each of the three months ended March 30, 2008 and April 1, 2007. Interest expense remained essentially the same as the decrease in interest expense resulting from our redemption of $96.4 million aggregate principal amount of our zero coupon convertibles notes due 2008 in November 2007, and repurchase of $12.4 million and $2.5 million aggregate principal amount of our zero coupon convertible notes due November 2008 in January 2008 and February 2008, respectively, which were offset by increases in our short-term debts in Singapore and long-term debts in Thailand in the three months ended March 30, 2008, compared to the same period in 2007. Total outstanding interest-bearing debt was $648.0 million and $701.3 million as of March 30, 2008 and April 1, 2007, respectively.
Foreign Currency Exchange Gain (Loss)
     Net foreign currency exchange gain was $3.2 million in the three months ended March 30, 2008, compared to $0.1 million in the same period in 2007. These non-cash gains were due primarily to the fluctuations between the exchange rate of the U.S. Dollar and the Singapore Dollar, the South Korean Won, the Chinese Renminbi and in the case of the three months ended March 30, 2008, the Thai Baht.
Other Non-Operating Income (Expense), Net
     Net other non-operating expense was $0.7 million in the three months ended March 30, 2008 compared to net other non-operating income of $0.04 million in the three months ended April 1, 2007.
Income Tax Expense
     Quarterly income tax expense was calculated using an estimate of the effective tax rate for the year. Our consolidated income tax expense was $7.6 million in the three months ended March 30, 2008 compared to $7.7 million in the three months ended April 1, 2007. The $7.6 million tax expense included adjustments to the effective tax rate related to $2.9 million of tax benefits recognized during the three months ended March 30, 2008.
Liquidity and Capital Resources
     Our principal source of liquidity consists of cash flows from operating activities, bank facilities, debt financing, and our existing cash, cash equivalents and marketable securities. As of March 30, 2008, we had cash, cash equivalents and marketable securities of $278.7 million. We also have available lines of credit and banking facilities consisting of loans, letters of credit and bank guarantees, including those available to our consolidated subsidiaries, which amounted to an aggregate of $296.1 million, of which $111.5 million was utilized as of March 30, 2008. Our liquidity needs arise primarily from servicing our outstanding debts, working capital needs and the funding of capital expenditures and investments. Our capital expenditures are largely driven by the demand for our services, primarily to increase our packaging and testing capacity, to replace packaging and testing equipment from time to time, and to expand our facilities. Depending on business conditions, we expect our capital expenditures to be approximately $300 million in 2008 as our capital spending continues to be targeted at demand we see from our customers. We spent $55.2 million on capital expenditures in the three months ended March 30, 2008, compared to $56.8 million in the same period in 2007.
     On October 2, 2007, we consummated the previously announced definitive agreement with LSI Corporation (“LSI”) to acquire LSI’s assembly and test operation in Thailand for an aggregate purchase price of approximately $100.0 million, payable over the next four years. We financed $50.0 million of the purchase price with our working capital, including our current cash and cash equivalents, and issued promissory note bearing interest of 6.0% per annum for the remainder $50.0 million purchase price.
     On November 7, 2007, we redeemed $96.4 million aggregate principal amount of our zero coupon convertible notes due 2008 pursuant to demands for redemption from note holders in accordance with the indenture governing the zero coupon convertible notes. We paid a total amount of $114.1 million (including interest accrued up to November 7, 2007) in respect of the convertible notes redemption. We financed the redemption with cash and short-term borrowings.
     In January and February 2008, we repurchased $12.4 million and $2.5 million aggregate principal of our zero coupon convertible notes due 2008 for $14.7 million (including accrued interest) and $2.9 million (including accrued interest), respectively. We financed the repurchase of the $12.4 million and $2.5 million aggregate principal amount of these convertible notes with our cash and cash equivalents.
     On May 6, 2008, we gave notice of the exercise of our option to redeem the remaining $3.7 million principal amount, representing approximately 3.2% of the original outstanding principal amount, of our zero coupon convertible notes due 2008, in accordance with the terms of the convertible notes. The redemption price is equal to US$4.5 million (including accrued interest) and the redemption date is scheduled on June 6, 2008. We intend to fund the redemption with cash on hand.
     In January 2008, we announced our intention to effect a proposed capital reduction to return surplus share capital in an amount of up to $813.0 million to our shareholders. At an extraordinary general meeting held on March 17, 2008, our shareholders approved the proposed capital reduction. The proposed capital reduction is subject to and conditional upon us being able to obtain adequate debt financing to fund the cash distribution and the repayment of certain of our outstanding debt (including the redemption or repurchase of our senior notes that would otherwise restrict our ability to make the cash distribution and to finance the cash distribution) on terms and conditions acceptable to us. The amount of the cash distribution would accordingly be determined based on

 


 

the proceeds of such debt financing made available to us. The proposed capital reduction is also subject to (1) approval by the Singapore High Court and other applicable regulatory authorities and (2) our board of directors determining, following the satisfaction of the preceding conditions, that it is in the best interest to us, to effect the proposed cash distribution.
     At the annual general meeting in April 2008, our shareholders approved the repurchase of up to approximately 51 million ordinary shares (2.5% of the issued ordinary share capital as of the date of the annual general meeting). The approved amount for share repurchases under this shareholders’ mandate will terminate on the earlier of the date on which the next annual general meeting is held or the date which the approval is revoked or varied. As of March 30, 2008, we have not repurchased any shares. We may use our available funds, draw down on our available lines of credit or seek additional financing or a combination of these to finance our repurchase of our ordinary shares.
     We believe that our cash on hand, existing credit facilities and anticipated cash flows from operations will be sufficient to meet our currently anticipated capital expenditure requirements, investment requirements, share repurchases, as well as debt service repayment obligations through to March 2009. Our debt service repayment obligations through to March 2009 include our obligation to redeem at maturity our 2.5% convertible subordinated notes due June 2008 and our zero coupon convertible notes due November 2008. As of March 30, 2008, $134.5 million aggregate principal amount of our 2.5% convertible subordinated notes due 2008 remained outstanding, all of which were held by STSPL subsequent to its tender offer in May 2007, and $3.7 million aggregate principal amount of our zero coupon convertible notes due 2008 remained outstanding. Furthermore, we have assumed that STSPL will convert the $134.5 million aggregate principal amount of our 2.5% convertible subordinated notes due 2008 that it acquired in connection with its tender offer in 2007. However, STSPL has the option to convert or to hold the notes to maturity. If STSPL does not convert the 2.5% convertible subordinated notes due 2008, we will be required to redeem them at maturity in June 2008, which will put additional strain on our liquidity.
     If our capital requirements exceed our expectations as a result of higher than anticipated growth in the semiconductor industry, acquisition or investment opportunities, the expansion of our business or otherwise, or if our cash flows from operations are lower than anticipated, including as a result of an unexpected decrease in demand for our services due to a downturn in the semiconductor industry or otherwise, we may be required to obtain additional debt or equity financing from time to time depending on prevailing market conditions. In such events, there can be no assurance that additional financing will be available or, if available, that such financings can be obtained on terms favorable to us or that any additional financing will not be dilutive to our shareholders or detrimental to our creditors.
Total Borrowings
     As of March 30, 2008, our total debt outstanding consisted of $648.0 million of borrowings, which included $150.0 million of our 7.5% senior notes due 2010, $215.0 million of our 6.75% senior notes due 2011, $3.7 million of our zero coupon convertible notes due 2008, $134.5 million of our 2.5% convertible subordinated notes due 2008, and other long-term and short-term borrowings.
     In March 2007, we redeemed the remaining outstanding $31.5 million aggregate principal amount of our 1.75% convertible notes due 2007 (including interest) for an aggregate consideration of $36.8 million. The repurchase was financed with our current working capital, including our cash and cash equivalents.
     In May 2007, we issued 16.7 million ordinary shares upon conversion of $15.5 million aggregate principal amount of our 2.5% convertible subordinated notes due 2008.
     In October 2007, we consummated the previously announced definitive agreement with LSI pursuant to which STATS ChipPAC (Thailand) Limited acquired LSI’s assembly and test operations in Thailand for an aggregate purchase price of approximately $100.0 million. We funded the initial payment of $50.0 million of the aggregate purchase consideration with our cash and cash equivalents. STATS ChipPAC (Thailand) Limited issued a promissory note bearing interest of 6.0% per annum, payable annually, for the remainder of the purchase price. The amount payable to LSI under the promissory note after contractual netting of certain receivables from LSI of $3.2 million amounted to $46.8 million as of March 30, 2008. The promissory note is payable in annual installments of $20.0 million, $10.0 million, $10.0 million and $6.8 million over the next four years.
     In November 2007, we redeemed $96.4 million aggregate principal amount of our zero coupon convertible notes due 2008 pursuant to demands for redemption from note holders in accordance with the indenture governing these convertible notes. We paid a total amount of $114.1 million (excluding interest) in respect of the convertible notes redemption. We financed the redemption with cash and short-term borrowings.

 


 

     In January and February 2008, we repurchased $12.4 million and $2.5 million aggregate principal of our zero coupon convertible notes due 2008 for $14.7 million (including accrued interest) and $2.9 million (including accrued interest), respectively. We financed the repurchase of the $12.4 million and $2.5 million aggregate principal amount of these convertible notes with our cash and cash equivalents.
     STATS ChipPAC Korea Ltd. has lines of credit with Hana Bank and the National Agricultural Cooperation Federation Bank in South Korea with credit limits of $10.0 million and $5.0 million, respectively. These lines of credit bear interest at a rate of 2.8% per annum on these facilities. As of March 30, 2008, the Company had not used these lines of credit and there was no outstanding balance on these facilities. These lines of credit are subject to an annual review by the lenders for the continued use of the facilities.
     STATS ChipPAC Korea Ltd.’s term loan facility from Hana Bank in South Korea amounted to $25.0 million. During 2006, we borrowed $12.0 million under this facility to finance our purchase of a building and land in South Korea. This borrowing is repayable over eight equal quarterly installments from September 2007 to June 2009. In 2007, we borrowed an additional $3.6 million under this facility, which is repayable at maturity in June 2009. As of March 30, 2008, the interest rate for our $12.0 million loan was 4.6% per annum and the interest rate for our $3.6 million loan was 4.4% per annum. Interest is payable on a monthly basis. As of March 30, 2008, $0.6 million was held as a restricted deposit with the bank. These loans are secured by a pledge of land and a building with a combined net book value of $26.9 milliion as of March 30, 2008. As of March 30, 2008, $11.1 million of the loans was outstanding.
     In August 2006, STATS ChipPAC Taiwan Semiconductor Corporation obtained a floating interest rate loan facility of NT$3.6 billion (approximately $119.9 million based on the exchange rate as of March 30, 2008) with a syndicate of lenders, with Taishin Bank as the sponsor bank. The loan drawdowns must be made within 24 months from the date of first drawdown, which took place in February 2007. As of March 30, 2008, STATS ChipPAC Taiwan Semiconductor Corporation has drawn down NT$0.7 billion (approximately $23.3 million based on the exchange rate as of March 30, 2008) under this term loan facility. As of March 30, 2008, the interest rate on the loan was 3.6% per annum. The principal and interest on the loan is payable in nine quarterly installments commencing 24 months from first draw down date with the first eight quarterly installments each repaying 11% of the principal and the last quarterly installment repaying 12% of the principal. The proceeds from this facility were primarily used to repay debt under certain of STATS ChipPAC Taiwan Semiconductor’s other credit facilities. As of March 30, 2008, the outstanding balance on this facility was $23.3 million.
     Additionally, STATS ChipPAC Taiwan Semiconductor Corporation has NT$1.4 billion (approximately $45.6 million as of March 30, 2008) of bank and credit facilities from various other banks and financial institutions, of which $12.8 million borrowings was outstanding as of March 30, 2008. These credit facilities have varying interest rates ranging from 2.5% to 4.0% per annum and maturities ranging from 2008 through 2012.
     We have a $50.0 million line of credit with Bank of America. The loan bears an interest rate of 3.85% per annum. As of March 30, 2008, $50.0 million was borrowed against this facility. The principal and interest are payable at maturity in April 2008. We have the option to roll-forward the principal at maturity for a period of 1, 2, 3, or 6 months.
     We established a syndicated three-year revolving line of credit of $125.0 million in 2006. This line of credit was arranged by Oversea-Chinese Banking Corporation Limited and includes a total of six lenders. The facility is irrevocable by the bank syndicate for the three-year period unless we are in breach of covenants, including minimum tangible assets, interest coverage ratios and debt ratios, or an event of default occurs, such as a failure to pay any amount due under the line of credit. We cancelled the revolving line of credit on January 31, 2008.
Special Tax Status
     In February 2008, EDB offered us a new five-year tax incentive for our Singapore operations commencing July 1, 2007 whereby certain qualifying income will be subject to a concessionary tax rate of 5% instead of the Singapore statutory rate of 18%, subject to the fulfillment of certain continuing conditions.

 


 

Off-Balance Sheet Arrangements
We provided a tax guarantee to the South Korean tax authorities as discussed below. We have no significant investment in any unconsolidated entities. Our off-balance sheet commitments are limited to operating leases, royalty/license agreements and purchase obligations. Our total off-balance sheet obligations were approximately $269.7 million as of March 30, 2008.
Contractual Obligations
     Our total commitments on our loans, operating leases, other obligations and agreements as of March 30, 2008, were as follows (in thousands):
                                         
    Payments Due  
    Within                     More Than        
    1 Year     1-3 Years     3-5 Years     5 Years     Total  
On balance sheet commitments:
                                       
Zero coupon convertible notes due 2008 (1)(2)
  $ 4,452     $     $     $     $ 4,452  
2.5% convertible subordinated notes due 2008 (2)
    134,500                         134,500  
6.75% senior notes due 2011 (2)
                215,000             215,000  
7.5% senior notes due 2010 (2)
          150,000                   150,000  
Long-term loans (2)
    37,096       48,115       8,501             93,712  
Short-term loans
    50,300                         50,300  
Other non-current liabilities (3)
                             
 
                             
Total on balance sheet commitments
  $ 226,348     $ 198,115     $ 223,501     $     $ 647,964  
 
                             
Off balance sheet commitments:
                                       
Operating leases
  $ 12,966     $ 19,516     $ 17,805     $ 35,584     $ 85,871  
Royalty/ licensing agreements
    7,827       15,677       15,603             39,107  
Purchase obligations:
                                       
— Capital commitments
    88,406                         88,406  
— Inventory purchase commitments
    56,304                         56,304  
 
                             
Total off balance sheet commitments
  $ 165,503     $ 35,193     $ 33,408     $ 35,584     $ 269,688  
 
                             
Total commitments
  $ 391,851     $ 233,308     $ 256,909     $ 35,584     $ 917,652  
 
                             
 
Notes:
 
(1)   On maturity of our zero coupon convertible notes due 2008, we are required to pay the note holders 123.4% of the principal amount. On November 7, 2007, we redeemed $96.4 million aggregate principal amount of our zero coupon convertible notes due 2008 pursuant to demands for redemption from note holders in accordance with the indenture governing our zero coupon convertible notes due 2008. We paid a total amount of $114.1 million (including interest accrued up to November 7, 2007) in respect of the convertible notes redemption. In January and February 2008, we repurchased $12.4 million and $2.5 million aggregate principal of our zero coupon convertible notes due 2008 for $14.7 million (including accrued interest) and $2.9 million (including accrued interest), respectively. We financed the repurchases with our cash and cash equivalents. On May 6, 2008, we gave notice of the exercise of our option to redeem the remaining $3.7 million principal amount, representing approximately 3.2% of the original outstanding principal amount, of our zero coupon convertible notes due 2008, in accordance with the terms of the convertible notes. The redemption price is equal to US$4.5 million (including accrued interest) and the redemption date is scheduled on June 6, 2008. We intend to fund the redemption with cash on hand.
 
(2)   The convertible notes, senior notes, short-term and long-term loans agreements contain provisions for the payment of interest either on maturity or on a monthly, quarterly, semi-annual or annual basis at a stated rate of interest over the term of the debt. These payment obligations are not reflected in the table above. The interest payments due within one year, 1-3 years and 3-5 years amount to $32.0 million, $49.9 million and $15.2 million, respectively.
 
(3)   Our other non-current liabilities as of March 30, 2008 were $116.6 million, including $37.1 million related to retirement and severance benefits for our employees in South Korea and Thailand, which were not included in the table due to lack of contractual certainty as to the timing of payments. Also included in the other non-current liabilities as of March 30, 2008 was $24.9 million of liability for uncertain tax positions under FIN 48. We are unable to reasonably estimate the timing of the amount, therefore, the liability is excluded from the table.
Contingencies
     We are subject to claims and litigations, which arise in the normal course of business. These claims may include allegations of infringement of intellectual property rights of others as well as other claims of liability. We accrue liability associated with these claims and litigations when they are probable and reasonably estimable.
     In February 2006, the Company, ChipPAC and STATS ChipPAC (BVI) Limited were named as defendants in a patent infringement lawsuit filed in United States Federal Court for the Northern District of

 


 

California (the “California Litigation”). The plaintiff, Tessera Technologies, Inc. (“Tessera”), has asserted that semiconductor chip packaging, specifically devices having BGA and multi-chip BGA configurations used by the defendants infringe certain patents of Tessera. Tessera has further asserted that the Company is in breach of an existing license agreement entered into by Tessera with ChipPAC, which agreement has been assigned by ChipPAC to the Company.
     In May 2007, at Tessera’s request, the United States International Trade Commission (the “ITC”) instituted an investigation of certain of the Company’s co-defendants in the California Litigation and other companies, including certain of the Company’s customers (the “First ITC Investigation”). In addition, in April 2007, Tessera instituted an action in Federal District Court for the Eastern District of Texas against certain of the Company’s co-defendants in the California Litigation and other companies (the “Texas Action”). In the First ITC Investigation, Tessera seeks an order preventing the named companies from importing certain packaged semiconductor chips and products containing them into the United States. The Texas Action seeks damages and injunctive relief against the named defendants. Both the First ITC Investigation and the Texas Action allege infringement of two of the same patents asserted by Tessera in the California Litigation, and may involve some of the same products packaged by the Company that are included in the California Litigation.
     In January 2008, Tessera served on us a draft complaint that Tessera proposed to file with the ITC to request an investigation (the “Proposed Second ITC Investigation”) on us and other semiconductor package assembly service providers that are defendants in the California Litigation. On January 30, 2008, the Company filed a motion with the ITC seeking leave to intervene in the First ITC Investigation for the limited purpose of seeking to postpone the hearing date in the First ITC Investigation and extend the target date for the completion of the First ITC Investigation in order to seek consolidation with the Proposed Second ITC Investigation if and when Tessera actually filed the complaint and the Proposed Second ITC Investigation was initiated.
     In February 2008, the district court presiding over the California Litigation held that Tessera may file the draft complaint requesting the Proposed Second ITC Investigation with the ITC. In April 2008, Tessera filed the complaint with the ITC. The ITC has not yet decided whether to initiate the Proposed Second ITC Investigation. In the Proposed Second ITC Investigation, Tessera seeks an order to prevent us and other named companies from providing packaging or assembly services for certain packaged semiconductor chips incorporating small format non-tape BGA semiconductor packages and products containing them, for importation into the United States. The Proposed Second ITC Investigation alleges infringement of three of the same patents asserted by Tessera in the California Litigation.
     The district court in the California Litigation has vacated the trial schedule and stayed all proceedings pending a final resolution of the First ITC Investigation. The United States Patent and Trademark Office has also instituted reexamination proceedings on all of the patents Tessera has asserted in the California Litigation and the Proposed Second ITC Investigation. In February 2008, the First ITC Investigation was stayed pending the outcome of the United States Patent and Trademark Office’s reexamination proceedings; however, such stay was lifted in March 2008. It is not possible to predict the outcome of the California Litigation or the Proposed Second ITC Investigation, the total costs of resolving the California Litigation and the Proposed Second ITC Investigation, or when the stay in the California Litigation will be lifted; nor is it possible to predict the outcome of the First ITC Investigation or the Texas Action. Nor is it possible to predict the outcome of the Patent and Trademark Office proceedings or their impact on the California Litigation, the First ITC Investigation and the Proposed Second ITC Investigation.
     We believe that we have a meritorious defense to these claims and intend to defend the lawsuit(s) vigorously. A court or ITC determination that our provision of certain semiconductor assembly services may infringe the intellectual property rights of others could result in significant liability and/or require us to make material changes to its provision of such assembly services. Due to the inherent uncertainties of the lawsuit(s) and investigation(s), we cannot accurately predict the ultimate outcome and it could result in significant liability and/or injunction and could have a material adverse effect on our business, financial condition and the results of operations.
     In addition, we are subject to various taxes in the different jurisdictions in which we operate. These include taxes on income, property, goods and services, and other taxes. We submit tax returns and claims with the appropriate government taxing authorities, which are subject to examination and agreement by those taxing authorities. We will regularly assess the likelihood of adverse outcomes resulting from these examinations to determine adequacy of provision for taxes.
     In connection with the merger with ChipPAC, we assumed certain contingent liabilities. In 2002, an assessment of approximately 16.0 billion South Korean Won (approximately $16.2 million based on the exchange rate as of March 30, 2008) was made by the South Korean National Tax Service (“NTS”) relating to withholding tax not collected on the interest income on the loan between ChipPAC’s subsidiaries in South Korea and Hungary for the period from 1999 to September 2001. We do not believe that the prevailing tax treaty requires withholding on the transactions in question. ChipPAC has appealed the assessment through the NTS’s Mutual Agreement Procedure (“MAP”). On July 18, 2002, the Icheon tax office of the NTS

 


 

approved a suspension of the proposed assessment until resolution of the disputed assessment. The NTS required a corporate guarantee amounting to the tax assessment in exchange for the suspension. ChipPAC complied with the guarantee request on July 10, 2002. A further assessment of 2.7 billion South Korean Won (approximately $2.7 million based on the exchange rate as of March 30, 2008) was made on January 9, 2004 for the interest from October 2001 to May 2002. ChipPAC engaged in a MAP and obtained suspension of the additional proposed assessment by providing a corporate guarantee in the amount of the additional assessment. In June 2007, the NTS extended the MAP. Based on South Korean tax law, the extension period should not exceed 3 years. In the event that we are not successful with the appeal, the maximum amount payable including potential interest and local surtax as of March 30, 2008 is estimated to be 33.5 billion South Korean Won (approximately $33.8 million based on the exchange rate as of March 30, 2008). The final outcome of the resolution of this matter could result in significant liability and could have a material adverse effect on our business, financial condition and results of operations.
Cash Flows From Operating Activities
     In the three months ended March 30, 2008, cash provided by operations was $96.9 million compared to $75.8 million in the three months ended April 1, 2007. Cash provided and used by operations is calculated by adjusting our net income or loss by non-cash related items such as depreciation and amortization, share-based compensation expense, amortization of leasing prepayments, accretion of discount on certain of our outstanding convertible notes, amortization of debt issuance cost, loss or gain from sale of assets, deferred income taxes, foreign currency exchange loss or gain, minority interest, share of equity income and by changes in assets and liabilities. In the three months ended March 30, 2008, non-cash related items included $72.3 million related to depreciation and amortization (including amortization of capitalized debt issuance costs and leasing prepayments), $1.2 million related to share-based compensation expense, $0.03 million from the accretion of discount on certain of our convertible notes, $2.0 million from deferred taxes, $1.4 million from the minority interest in income of one of our subsidiaries, $0.3 million gain from the sale of equipment and $0.1 million equity loss from equity investments. In the three months ended April 1, 2007, non-cash related items included $61.4 million related to depreciation and amortization (including amortization of capitalized debt issuance costs and leasing prepayments), $2.9 million related to share-based compensation expense, $1.4 million from the accretion of discount on certain of our convertible notes, $5.8 million from the deferred taxes, $1.2 million from the minority interest in income of one of our subsidiaries, $0.7 million loss from the sale of equipment and $0.3 million equity loss from equity investments.
     Working capital uses of cash included decreases in amount due to affiliates and increases in amount due from affiliates, inventories, and other receivables, prepaid expenses and other assets. Working capital source of cash included decreases in accounts receivables, and increases in accounts payables, accrued operating expense and other payables. Inventories as of March 30, 2008 were higher as compared to December 30, 2007 levels. Accounts receivables were lower compared to December 30, 2007 mainly due to lower quarterly revenues. Additionally, accounts and other payables decreased as compared to December 30, 2007 primarily due to lower quarterly purchases.
Cash Flows From Investing Activities
     In the three months ended March 30, 2008, cash used in investing activities was $87.3 million compared to $39.9 million in the three months ended April 1, 2007. The primary usage of cash in investing activities was related to the acquisition of property and equipment, net of changes in payables related to property, plant and equipment purchases, of $71.2 million in the three months ended March 30, 2008 compared to $55.8 million during the same period in 2007. We increased our capital expenditure in the three months ended March 30, 2008 compared to the same period in 2007 primarily to meet the demand from our customers. In the three months ended March 30, 2008 and April 1, 2007, we invested $2.3 million and $0.6 million, respectively, in the acquisition of software, licenses and other intangible assets. In the three months ended March 30, 2008, we purchased marketable securities of $32.9 million. No marketable securities were purchased in the three months ended April 1, 2007. In the three months ended March 30, 2008 and April 1, 2007, we received proceeds from the sale and maturity of our marketable securities of $12.1 million and $13.3 million, respectively.
Cash Flows From Financing Activities
     In the three months ended March 30, 2008, cash used in financing activities was $13.4 million compared to cash used in financing activities of $51.3 million in the three months ended April 1, 2007. In the three months ended March 30, 2008, we did not incur any new borrowings and repaid $1.9 million compared to new borrowings of $15.5 million and repayment of 39.3 million for the same period in 2007. In the three months ended March 30, 2008, we repurchased $14.9 million aggregate principal amount of our $115.0 million zero coupon convertible notes (including accrued interest) at an aggregate consideration of $17.6 million. In the three

 


 

months ended April 1, 2007, we redeemed the remaining $31.5 million aggregate principal amount of our 1.75% convertible notes due 2007 (including interest) at an aggregate consideration of $36.8 million. We did not make any capital lease payments in the three months ended March 30, 2008 compared to $1.8 million of capital lease payments made in the same period in 2007. In the three months ended March 30, 2008 and April 1, 2007, we increased our restricted cash by $0.08 million and reduced our restricted cash by $0.004 million, respectively. In the three months ended March 30, 2008 and April 1, 2007, we received $6.2 million and $11.1 million, respectively, from the issuance of new ordinary shares through our share plans. The total numbers of ordinary shares issued in the three months ended March 30, 2008 and April 1, 2007 were 9.6 million and 16.6 million, respectively.

 

-----END PRIVACY-ENHANCED MESSAGE-----